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Abstract 	
The enteric pathogen Salmonella causes both severe systemic infection and 
acute gastroenteritis, commonly known as food poisoning, in humans. It is 
therefore responsible for millions of food and water born infections worldwide 
each year and has a significant burden on global health. Typhoid fever is a 
serious, life-threatening illness while gastroenteritis caused by Salmonella is 
often fatal to at-risk individuals such as the immunocompromised, the elderly 
and infants. The human innate immune system combats Salmonella infection 
with both reactive oxygen and reactive nitrogen species (ROS and RNS) 
largely produced by macrophages. Both ROS and RNS are capable of 
damaging bacterial DNA, lipids and proteins, inhibiting Salmonella replication 
and survival. Nitric Oxide (NO), a free radical and cytotoxin, is one such RNS 
produced by the host immune system that acts as an antibacterial defence 
against Salmonella. In order to survive in the host Salmonella must therefore 
employ mechanisms to detoxify NO it encounters both endogenously and 
exogenously. Currently three enzymes are well-characterised as mechanisms 
by which Salmonella detoxifies NO, however Salmonella’s ability to survive 
without these three enzymes suggests the existence of other, yet unidentified, 
NO detoxification genes. 
In this study, various Salmonella genes shown to be up-regulated under 
nitrosative stress in preliminary data were further investigated and their role in 
NO detoxification characterised. Single and combination deletion strains were 
constructed and resultantly showed sensitivity to both nitrosative and 
oxidative stress. This study also examined the regulation of the periplasmic 
nitrate reductase of Salmonella, NapA, in relation to the SPI-1 transcriptional 
activator HilA. Results of this research implicate a role for HilA as a negative 
regulator of napA expression. 					
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1.1  Salmonella 
1.1.1  Physiology  
Salmonella are gram-negative, rod-shaped bacteria of the Enterobacteriacae 
family (Prior et al, 2009).  These microorganisms range from 0.7 to 1.5µm in 
diameter and 2-5µm in length with peritrichous flagella which allow for their 
high motility (Fàbrega & Vila, 2013). As with other Gram-negative bacteria, 
Salmonella possess a thin peptidoglycan layer between their inner 
cytoplasmic and outer cell membrane. A major component of this outer cell 
membrane is lipopolysaccharide (LPS), which is capable of activating a 
variety of host-immune responses. A constituent of LPS is the O-
polysaccharide or antigen which is used in conjunction with the bacterial 
flagellin proteins (H1 and H2 antigens) to differentiate between serotypes 
(McQuiston et al, 2011).  As a facultative anaerobe Salmonella is capable of 
survival and growth in either aerobic or anaerobic conditions, a characteristic 
which contributes to its success as an enteric pathogen (Rowley et al, 2012).     
 
1.1.2  Nomenclature  
There are over 2,500 serovars of Salmonella currently characterized, with 
new serovars identified each year (Popoff et al, 2004). All recognized 
serovars belong to one of two species, Salmonella bongori or Salmonella 
enterica (Fàbrega & Vila, 2013) (Figure 1). Salmonella nomenclature here 
becomes considerably more complex, as both species may be divided further 
into subspecies on the basis of the Kauffmann-White scheme (Fàbrega & 
Vila, 2013; Su & Chiu, 2007). The subspecies S. bongori consists of only 22 
serovars that rarely infect humans and are predominately found in reptiles or 
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in the environment (Fàbrega & Vila, 2013). In comparison, S. enterica 
consists of six subspecies, including S. enterica subspecies enterica (I) that 
contains almost all serovars which cause disease in domestic animals and 
humans (Grimont & Weill, 2007; Fàbrega & Vila, 2013). Strains belonging to 
the species S. enterica may also be classified into 67 serogroups on the basis 
of their O surface antigen or, when differentiated by both O and H antigens, 
into 2,557 serovars. Of these, 1,531 serovars are found in the S. enterica 
subspecies enterica and are usually named for the geographical region in 
which they were identified (Fàbrega & Vila, 2013, Popoff et al, 2004). 
Exceptions include the serovars Salmonella enterica ssp. enterica serovar 
Typhi (S. Typhi), Salmonella enterica ssp. enterica serovar Paratyphi (S. 
Paratyphi A, B and C), Salmonella enterica ssp. enterica serovar 
Typhimurium (S. Typhimurium) and Salmonella enterica ssp. enterica serovar 
Enteritidis (S. Enteritidis) all of which are prominent causes of infections in 
humans (Fàbrega & Vila, 2013). Serovars display varied host adaption and 
restriction, such as S. Typhi, S. Paratyphi A, B and C, which exclusively infect 
humans and some nonhuman primates to cause enteric fever (Pascopella et 
al, 1995). However, most strains have a broad host range and are able to 
infect both animals and humans, though the disease caused may vary 
according to the host. For instance, S. Typhimurium is a cause of acute 
gastroenteritis in humans but, as its name suggests, causes a systemic 
disease similar to Typhoid in mice (Suar et al, 2006). S. Dublin is adapted to 
cattle, where it is capable of causing systemic and enteric disease, whilst in 
humans S. Dublin is an infrequent cause of septicemia. Furthermore, in 
laboratory settings S. Dublin was shown to cause Typhoid fever-like infections 
	 18	
in mice (Suar et al, 2006; Barrow et al, 1994). The ability of Salmonella 
enterica serovars to manifest as distinctive diseases in different hosts is a 
highly researched topic in which much remains to be elucidated.  
  
Figure 1: The Salmonella genus. The genus Salmonella may be divided into 
two subspecies, S. bongori and S. enterica. S. bongori contains five 
subspecies, whilst S. enterica contains six subspecies, which can be further 
divided into serovars on the basis of their O and H antigens. S. enterica 
contains all serovars which cause disease in domestic animals and humans. 
These serovars may be either Typhoidal, meaning that they cause Typhoid 
fever in humans, or non-Typhoidal serovars, which only cause gastrointestinal 
and extraintestinal infections in humans. (Figure adapted from Hurley et al, 
2014.) 
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1.1.3 Epidemiology  
In terms of clinical manifestation Salmonella serotypes cause one of three 
distinctive illnesses; Typhoid Fever, bacteremia or enteritis (Santos et al, 
2001). Serotypes which cause Typhoid are therefore known accordingly as 
Typhoidal strains, whilst those that result in gastroenteritis and bacteremia are 
referred to as non-Typhoidal.  Due to differences in disease recording 
between countries, and allowing for unreported and undiagnosed cases of 
Salmonellosis, statistics reflecting disease incidence are hard to come by and 
somewhat unreliable. However, it is thought that worldwide Salmonella kills 
some 1 million people each year (Crump et al, 2004).  The current estimation 
stands at some 20-30 million cases and 200,000 deaths worldwide associated 
with Typhoid Fever annually (Wong et al; 2015, Zhang et al, 2008, Crump et 
al, 2004). Whilst the incidence of gastrointestinal infections associated with 
non-Typhoidal Salmonella (NTS) is estimated to be some 93 million cases 
each year (Majowicz et al, 2010).  However, such figures may be highly 
conservative estimates due to the self-limiting nature of the majority of 
Salmonella strains; most infections in healthy persons are not reported or 
treated, as symptoms are non-life-threatening, with the individual recovering 
after 3-7 days. Demographics most at risk for infection include the elderly, 
children and the immunosuppressed, and Salmonella may cause severe 
complications or even fatality in these individuals. Whilst gastroenteritis is 
common worldwide, Typhoid fever is rare across Europe and the USA.  It is 
however widespread throughout sub-Saharan Africa and Asia, with incidence 
being particularly high where sanitation is poor (Prior et al, 2009) (Figure 2). 
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Typhoid is therefore a prominent health concern for endemic people and for 
those travelling to such destinations.   
 
 
 
1.1.3.1 Salmonella Typhimurium 
This study involves the use of S. Typhimurium, a serovar belonging to the S. 
enterica subspecies enterica, which is a significant cause of non-Typhoidal, 
acute gastrointestinal infection in humans. This particular serovar, as its name 
implies, is also capable of causing a systemic disease in mice similar to that 
of Typhoid and is therefore prominently used in the laboratory-based study of 
Typhoid and host-pathogen interactions (Santos et al, 2001; Suar et al, 2006). 
S. Typhimurium has a broad host range including not only rodents and 
Figure 2: Epidemiology of Typhoid Fever. Map showing the distribution of 
Salmonella enterica Serotype Typhi (1990-2002) (Figure taken from Crump 
et al, 2004). 	
	 21	
humans, but cattle, poultry and other mammals (Garai et al, 2012). Like the 
rest of its genus, S. Typhimurium has a wide temperature range with an 
optimum of 37°C, conferring the ability to survive and colonise a diverse 
assortment of environments. Also, as will be discussed in this study, S. 
Typhimurium has the ability to adapt and survive a multitude of stress factors, 
including, but not limited to, heat, oxidative and nitrosative stress.  
 
1.1.4 Typhoid Fever  
Typhoid Fever is a severe and systemic illness caused by host-adapted 
Typhoidal strains S. Typhi and S. Paratyphi and which has a mortality of 10-
30% without treatment. Infection occurs most commonly via the fecal-oral 
route (Anwar et al, 2014). The bacteria enter through the intestine and are 
disseminated in the blood to the intestinal lymph nodes, liver and spleen 
where they multiply (Bäumler et al, 2008). Infected individuals typically 
present with chills, headache, sore throat, constipation or diarrhoea and 
myalgia prior to the onset of fever (Anwar et al, 2014). The illness progresses 
with increasing malaise, bacteraemia and diffuse enterocolitis. Enterocolitis in 
Typhoid is associated with hypertrophy which may lead to necrosis in Peyer’s 
Patches (PP) and mesenteric lymphoid tissue. In severe cases necrosis and 
ischemia of the tissue results in perforation of the ulcerated Peyer’s Patches 
and subsequent haemorrhage (Sirinavin & Garner, 2000; Everest et al, 2001).  
This may in turn lead to peritonitis, septicaemia and death (Prior et al, 2009; 
Everest et al, 2001).  Gastrointestinal bleeding may also occur, and is seen in 
approximately 10% of patients (Parry et al, 2002). Individuals may display 
bradycardia, hepatomegaly, splenomegaly and ‘rose spots’; bacterial emboli 
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which are typical of enteric fever and appear as a rash from as early as a 
week after infection. In 5-10% of cases the infection may manifest 
neuropsychiatrically, known as typhoid encephalopathy, with psychosis and 
confusion (Anwar et al, 2014).  Diagnosis involves the detection of bacteria in 
the blood through PCR or culture (Hosoglu & Wain, 2008). The Widal test has 
been traditionally used as a method of detection for Typhoid and in some 
developing countries is the only laboratory means of diagnosis for enteric 
fever (Olopoenia & King et al, 2000). This serological test employs 
agglutination to demonstrate the presence of H and O Salmonella antigens in 
the serum of the infected individual. However, doubts have been raised about 
the accuracy of this test, which often produces false-positive results due to 
cross-reactivity with other infectious organisms. Positive results may also be 
caused by previously contracted enteric fever, typhoid vaccination or a 
response to antibodies present in populations where Typhoid is endemic. 
Furthermore, whilst the test is strongly positive in the later stages of infection, 
serological tests are inaccurate until approximately a week after initial 
infection (Younis et al, 2009). Newer diagnostic approaches have looked at 
the detection of circulating IgA in order to improve sensitivity and specificity 
(Sheikh et al, 2009).  In 2004 it was estimated that the annual frequency of 
Typhoid was approximately 27 million worldwide (Crump et al, 2004; Anwar et 
al, 2014). Globally it is estimated that the annual number of deaths from 
Typhoid stands within the range of 200,000-800,000; based on the 1-4% 
mortality rate of invasive S. Typhi (Crump et al, 2004, Breiman et al, 2012, 
Steele et al, 2008). As such Typhoid is a significant health issue worldwide.   
	 23	
1.1.5 Gastroenteritis  
Acute gastroenteritis in humans is caused by several Salmonella serovars, 
though S. Enteriditis and S. Typhimurium are most commonly isolated in 
clinical practice (Prior et al, 2009; Fábraga & Vila, 2013). In fact, the Global 
Food-borne Infections Network (GFN) suggests 80% of all human cases of 
NTS worldwide are attributable to S. Typhimurium or S. Enteritidis (Haeusler 
& Curtis, 2013).  
The infectious dose for non-typhoidal strains of Salmonella ranges from 106-
108 organisms for healthy adults, though infants, the elderly and individuals 
with underlying conditions are more susceptible (Chen et al, 2013). Globally, 
the estimated number of annual gastroenteritis cases resulting from NTS 
infection is 93.8 million, with some 155,000 deaths (Gal-Mor et al, 2014; 
Majowicz et al, 2010.) Infection occurs through the ingestion of contaminated 
food or water and is followed by an incubation period varying from 4 to 72 
hours dependent on the host (Chen et al, 2013, Velge et al, 2005). The 
spectrum of severity for gastroenteritis is broad and may range from mild to 
acute forms. The infection presents with fever and chills, nausea and 
vomiting, abdominal cramping and diarrhoea (Chen et al, 2013). Diarrhoea 
may contain blood, mucus and lymphocytes but is usually self-limiting after a 
period of 3-7 days (Prior et al, 2009; Chen et al, 2013). As such infection 
rarely requires treatment, though in young, elderly or immunocompromised 
patients complications such as bacteraemia or extraintestinal focal infections 
(EFIs) may arise which require antimicrobial therapy (Chen et al, 2013; Prior 
et al, 2009; Chen et al, 2007). Bacteraemia occurs in 10-15% of infected 
individuals, and this may progress to focal infection such as meningitis, and 
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bone and joint infection (Chen et al, 2013).  Acute gastrointestinal infections 
which lead to complications may sometimes prove fatal, particular in high-risk 
individuals. However, in most immunocompetent individuals recovery is 
prompt, though bowel habits may be effected for up to several months after 
the illness.  Following infection Salmonella bacteria are shed in the faeces, 
usually for a period of 5 weeks, though this is sometimes prolonged in young 
children (Chen et al, 2013).  This short-term asymptomatic excretion following 
infection is known as convalescent carriage, whereas periods of excretion 
lasting for more than a year is defined as chronic carriage (Haeusler & Curtis, 
2013; Buchwald & Blaser, 1984).   
 
1.1.6 Sources of Infection 
Salmonella infection occurs most commonly through contaminated foods or 
water, although human to human and animal to human transmission is also 
possible (Prior et al, 2009). This latter form is known as zoonotic transmission, 
and in the case of Salmonella can occur from contact with cats, dogs, rodents 
and, in particular, reptiles or amphibians (Hohmann, 2001; Mermin et al, 2004; 
Braden, 2006; Haeusler and Curtis, 2013).  Poultry and egg products are 
common sources of Salmonella, as well as beef and pork. (Muhlig et al 2014; 
Adak et al, 2005). However, fruits and vegetables may also act as reservoirs 
for Salmonella. For instance, recent Salmonella outbreaks have been 
associated with contaminated products such as sprouts, tomatoes, peanuts 
and spinach (Gal-Mor et al, 2014). In 2008 there was a severe outbreak of 
Salmonellosis in the US from jalapeño peppers (Mody et al, 2011).  More 
recently, in 2014, there was an outbreak of S. Newport originating from 
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cucumbers which caused some 275 diagnosed illnesses in the US (Bayer et 
al, 2014).  This highlights the risk that Salmonella poses for industrialized 
countries as well as low-income nations. 
 
1.2 Disease Progression and Host-Pathogen Interactions 
1.2.1 Physiology of the Host Gastrointestinal Tract 
The mammalian gastrointestinal system functions primarily as a gateway by 
which nutrients and water can enter the body (Saffrey, 2014). As such it is 
exposed to a variety of enteric pathogens through the ingestion of food and 
water and is thus equipped with various methods of destroying these 
microorganisms.  The first of these defences are the salivary lysozymes in the 
mouth that have the ability to cause bacterial cell lysis and function as part of 
the innate immune system.  Enteric pathogens that survive are then exposed 
to the acidic environment of the stomach, which at a pH of 2 serves as an 
effective host-defence against microorganisms. In the immediate post-
prandial period acidity has even been known to fall as low as pH1 (Levy et al, 
2006; Rychlik & Barrow, 2005). Individuals with alchlorhydria, or those 
undergoing treatment with proton-pump inhibitors or large quantities of 
antacids are therefore more susceptible to infection due to a less acidic 
gastric barrier (Tennant et al, 2008).  A further defence is nitric oxide (NO) 
produced in the stomach from dietary and salivary nitrate.  At pH2 and lower 
reactive nitrogen species (RNS) such as NO are directly bactericidal (Bourret 
et al, 2008; Henard & Vázquez-Torres, 2011).  Any bacteria that survive the 
considerable obstacle of the stomachs acidic environment and RNS then 
move into the small intestine by the pyloric sphincter.  Here, bile salts and 
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pancreatic juices released in the gut lumen cause a rise to an alkaline pH, 
preventing acidic damage to the intestine and aiding in the absorption of 
various nutrients and vitamins (Levy et al 2006). The small intestine itself is 
some 16 feet long with a 1-inch diameter and an exceptionally large surface 
area owed to the presence of villi and microvilli. (Gracz & Magness, 2014). 
The small intestine may also be differentiated into sections, with the beginning 
known as the duodenum, the middle is referred to as the jejunum and the final 
part of the small intestine, the ileum (Santaolalla et al, 2011). It is a multi-
layered tissue, composed of the intestinal mucosa, submucosa, muscularis 
and serosa. The intestinal mucosa is composed of the intestinal epithelium 
and the lamina propria. The intestinal epithelium itself lines the surface of the 
small intestine and acts as a vital barrier between the intestinal lumen and the 
rest of the body. It is a crypt-villus structure composed of six differentiated 
epithelial cell types all originating from a common stem cell progenitor.  The 
stem cells of the small intestine are the crypt base columnar (CBC) cells, 
which are interspersed between Paneth cells at the bottom of the crypt. These 
stem cells underdo asymmetric division, with one daughter cell replacing the 
original stem cell at the crypt base; whilst the other goes on to become a 
progenitor cell committed to producing a particular mature cell lineage. This 
progenitor cell moves up out of the crypt and trans-amplifying (TA) 
compartment and matures into a specialized epithelial cell type as it migrates 
to the top of the villus. Once at the top of the villus the mature cell undergoes 
apoptosis and is shed into the gut lumen. This process of continuous 
proliferation of epithelial cells from the crypt base and migration to the villus 
apex allows for rapid and constant renewal of the epithelium of the small 
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intestine. On average the intestinal epithelium is renewed every 4-5 days 
(Clevers, 2011). The cell types comprising the intestinal epithelium include 
enterocytes, which posses a luminal brush border, goblet and 
enteroendocrine cells which secrete mucus and hormones respectively, tuft 
cells which sense luminal contents and Paneth cells which reside near the 
bottom of the crypt and provide the stem cell niche. Paneth cells are important 
for their role of secreting lysozymes, defensins and other bactericidal products 
that serve as a defence against enteropathogenic colonisation. Finally, 
microfold (M) cells are uniquely localized to the specialized-epithelium 
covering the lymphoid follicles within the wall of the small intestine known as 
Peyer’s patches (PP). PP are aggregated lymphoid nodules which have a 
critical role in mucosal immunity; together with the appendix, lymphoid follicles 
and mesenteric lymph nodes, they form the gut associated lymphoid tissue 
(GALT). PP are dome-shaped and situated in the small intestinal wall, being 
most numerous near the terminal ileum (Cornes, 1965). These follicles lack 
goblet cells and therefore have a reduced mucus layer, instead they are 
largely covered by columnar epithelial cells and contain the aforementioned M 
cells. M cells lack microvilli on their apical surface, instead having broader 
microfolds. They also contain a deep, intraepithelial cavity which houses a 
variety of mononuclear cells (Kucharzik et al, 2006). M cells are proposed to 
act as an antigen sampling system by serving as a gateway through which 
luminal antigens are transported to the intestinal immune system, allowing an 
immune response to be mounted if necessary (Clevers, 2011; Zoetendal et al, 
2006). Whilst M cells are important for inducing an effective immune response 
in the gut, they also present a weak point in the intestinal epithelial barrier 
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through which invasive pathogens, such as Salmonella, may invade the body 
(Kucharzik et al, 2006).  
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Figure 3: Morphology and structure of the intestinal epithelium. The 
intestinal epithelium is a crypt-villus structure. Intestinal epithelium cells 
(IEC) create a barrier between luminal microbiota and the mucosal immune 
system. Intestinal epithelial stem cells (IESC) reside at the base of the 
crypt in the niche maintained by Paneth cells and undergo asymmetric 
division to allow continuous renewal of the epithelial cell layer. With the 
exception of Paneth Cells which move to the bottom of the crypt, progenitor 
cells migrate up the crypt-villus axis and become differentiated IECs, such 
as Globlet cells, enterocytes or enteroendocrine cells. Once these cells 
reach the villus axis they undergo apoptosis and are shed into the lumen. 
Goblet cells and Paneth cells secrete mucus and antimicrobial proteins 
(AMPs) in an effort to exclude and combat pathogens on the epithelial 
surface. Secretory IgA (sIgA) is also released into the lumen as a defence 
against pathogens. Microfold cells (M cells) mediate the movement of 
antigens in the gut lumen across the epithelial barrier to Peyer’s Patches 
and associated dendritic cells (DC) and macrophages. (Figure taken from 
Peterson & Artis, 2014).  
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1.2.2 Infection Process 
The infectious dose of Salmonella varies depending on bacterial strain, the 
physiological health of the host and the food with which the bacteria are 
consumed (Prior et al, 2009; Darwin and Miller, 1999).  The first stage of 
Salmonella infection involves survival of the early gastrointestinal tract to 
successfully reach the host intestine where it can then begin the invasive 
stage of infection during which it infiltrates the host intestinal epithelium.  
 
1.2.2.1 Gastrointestinal Phase  
Once ingested, Salmonella is exposed to the acidic environment of the 
stomach which at a pH of 3-4 serves an effective host defence against 
Salmonella survival (Prior et al, 2009) In the immediate post-prandial period 
acidity has even been known to fall as low as pH1 (Levy et al, 2006; Rychlik & 
Barrow, 2005). A further defence is nitric oxide (NO) produced in the stomach 
from dietary and salivary nitrate.  At pH2 and lower reactive nitrogen species 
(RNS) such as NO are directly bactericidal against many micro-organisms 
(Bourret et al, 2008; Henard & Vázquez-Torres, 2011).  In order to survive this 
acidic environment Salmonella switches on genes initiating an Acid-tolerance 
Response (ATR). The ATR is triggered in Salmonella by exposure to acidic 
foods or environment and enhances the organism's resistance to acidity. The 
expression of more than 50 acid shock proteins are involved in the ATR, 
controlled by a variety of signalling pathways (Bourret et al, 2008). Any 
bacteria that survive the considerable obstacle of the stomach’s acidic 
environment and RNS then move into the small intestine by the pyloric 
sphincter. They must then survive killing by digestive enzymes, bile salts, 
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RNS, antimicrobial peptides, secretory IgA and other innate immune defences 
in order to reach the underlying epithelium (Haraga et al, 2008).  Here 
Salmonella encounters further host-resistance in the form of the gut 
commensal flora, which act competitively against enteropathogenic 
colonisation (Fàbrega & Vila, 2013). Current data seems to suggest that 
Salmonella may outcompete this high density of commensal microbiota as a 
result of gut inflammation which acts beneficially for the pathogen. In brief, 
inflammation caused by the host-response appears to confer a growth 
advantage upon Salmonella, as nutrient access becomes limited. The 
pathogen, being motile and capable of chemotactic movement is able to 
obtain the high-energy nutrients localized by mucosal inflammation, leading to 
out-replication and growth over gut microbiota (Fàbrega & Vila, 2013). 
Furthermore, reactive oxygen species (ROS) produced in the gut in response 
to Salmonella react with thiosulfate present in the intestine to form 
tetrathionate. Tetrathionate can be utilised by Salmonella as an electron 
acceptor, providing a growth advantage for Salmonella in the anaerobic 
conditions of the intestinal mucosal layer (Fàbrega & Vila, 2013). Another 
advantage arises from the Salmonella virulence factor SopE, which induces 
the expression of nitric oxide synthase in the gut, leading to the production of 
NO. The reaction of NO with ROS leads ultimately to the formation of nitrate 
which, having a higher standard redox potential than tetrathionate, is then 
used by Salmonella as an anaerobic electron acceptor. This increased nitrate 
respiration leads to greater Salmonella growth, aiding Salmonella in 
outcompeting commensal microbiota. Ultimately Salmonella that survives 
these accumulative host-defences will encounter and adhere to the brush 
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border membrane of the epithelial cells of the gut (Prior et al, 2009; Levy et al, 
2006).  
 
1.2.2.2 Invasive Phase  
Salmonella entry into the gastrointestinal epithelia appears to occur 
preferentially through adherence and entry into the microfold-cells (M cells) of 
the Peter’s Patches (PP) in the intestinal epithelium (Prior et al, 2009; 
Fàbrega & Vila, 2013).  It has also been observed that Salmonella can invade 
via normally non-phagocytic enterocytes (Fàbrega & Vila, 2013; Prior et al, 
2009; Haque et al, 2004). Shortly after adhesion to the epithelial membrane 
Salmonella virulence factors interact with host cell signalling pathways to 
induce significant cytoskeletal rearrangement (Fàbrega & Vila, 2013). This 
results in membrane ruffling, leading to the internalisation of the bacteria into 
the cell and engulfment into a vesicle known as Salmonella containing 
vacuole (SCV) (Fàbrega & Vila, 2013). This intracellular compartment is 
distinct from the classical phagosome and its formation and maintenance is 
controlled by the bacterium itself, providing a niche in which Salmonella can 
survive and replicate (Fàbrega & Vila, 2013). Simultaneously, the host-
immune system is alerted to the presence of the bacteria by Toll-like 
receptors (TLR) on host cells. These receptors recognize small molecular 
motifs present on bacterial cell surfaces known as pathogen-associated 
molecular patterns (PAMPs) (Prior et al, 2009; Mumy & McCormick, 2005). 
These PAMPs identify the bacteria to the host immune system as non-self 
and therefore stimulate an innate immune response against Salmonella (Prior 
et al, 2009). PAMPS include the lipopolysaccharide (LPS) that is part of the 
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Salmonella cell wall, and various secreted bacterial proteins (Prior et al, 
2009). This leads to recruitment and transmigration of phagocytes into the 
intestinal lumen from the submucosa and stimulates the production of 
proinflammatory cytokines such as tumour necrosis factor alpha (TNF-a) and 
interleukin-8 (IL-8) (Fàbrega & Vila, 2013). Following bacterial internalisation 
into the SCV, Salmonella again interacts with host-cell signalling pathways to 
reform the apical epithelial brush border (Fàbrega & Vila, 2013). As 
Salmonella bacteria preferentially invade the intestinal epithelium by entry into 
M cells, they are directly transported to the lymphoid cells underlying PP 
(Fàbrega & Vila, 2013). The invading bacteria are engulfed by various 
phagocytes, including neutrophils and inflammatory monocytes, which are 
recruited from the blood as a result of inflammatory signals (Fàbrega & Vila, 
2013). Systemic dissemination of Salmonella is facilitated by infected 
phagocytes which migrate via the blood stream or lymphatic system to the 
liver and spleen (Fàbrega & Vila, 2013). Salmonella then multiply in these 
organs before re-entering the blood, known as secondary bacteriosis, and 
being transported back to the intestinal tract via the gall bladder. With Typhoid 
the secondary exposure of the PP to the bacteria causes damage which may 
result in ulceration, bleeding and necrosis, leading to perforation of the PP 
and in severe cases, death (Everest et al, 2001).  
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Figure 4: Systematic invasion of Salmonella. Salmonella breach the 
intestinal epithelium via M cells in Peyer’s patches (PP) and are taken up by 
macrophages which transport them to the mesenteric lymph nodes. They then 
utilise these immune cells to migrate via the blood to the liver, spleen and 
bone marrow (not shown) where the bacteria multiply. Salmonella then re-
enters the intestinal tract via the gall bladder, resulting in tissue damage to PP 
that may lead to ulceration and necrosis (Figure taken from Everest et al, 
2001).  
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1.3 Salmonella Pathogenicity Islands 
The ability of Salmonella to cause disease is dependent on its ability to invade 
non-phagocytic host cells, which in turn is largely reliant on a group of 
virulence genes known as Salmonella pathogenicity islands (SPI). There are 
currently five identified SPIs (SPI-1 to 5) known to be involved in Salmonella 
virulence. Together with other pathogenic components, including the pST 
plasmid-carried spv operon, various adhesions, flagella and essential genes 
involved in biofilm formation, SPIs are responsible for the virulence of 
Salmonella (Ellermeier & Slauch, 2007).  SPI-1 is of particular note, being vital 
for the invasion of epithelial cells in the host intestinal lumen by arbitrating 
rearrangement of host cell actin cytoskeletons to facilitate internalization of 
the bacteria (Fàbrega & Vila, 2013). The importance of SPI-1 is demonstrated 
by SPI-1 mutants, which are unable to infect the host through the oral route 
and are incapable of in vitro invasion of enterocytes (Lucas & Lee, 2001).  
The genes of the SPI-1 locus encode a type three secretion system (TTSS), a 
structure which resembles a hypodermic syringe and through which 
Salmonella translocates effector proteins into host cells (Srikanth et al, 2011; 
Prior et al, 2009) (Figure 5A).  The Salmonella TTSS is composed of some 
20-30 proteins, most of which have a structural role in the formation of the 
‘needle’ (Kubori et al, 2000). The remaining are secreted effector proteins 
including, but not limited to, SipA, SipC, SopB, SopE and SopE2 (Agbor & 
McCormick, 2011).  Whilst the large majority of secreted effectors involved in 
the invasion process are located within SPI-1, additional effectors appear to 
be encoded elsewhere on the chromosome (Fàbrega & Vila, 2013; Lostroh & 
Lee, 2001). The needle complex itself is encoded by the so-called prg/org and 
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inv/spa operons, whilst the sic/sip operon encodes the effector proteins. It is 
the pore-forming structure called the translocon, composed of SipBCD, which 
inserts itself into host cell membrane and ‘injects’ these effectors to the host 
cytosol. Together these proteins then function to alter cytoskeletal structure 
and induce membrane ruffling, leading to eventual engulfment of the 
Salmonella bacterium into the cell (Figure 5B). SopE, SopE2 and SigD (itself 
encoded on SPI-5) are largely responsible for the initiation of cytoskeletal 
remodelling. SopE acts as a guanidine exchange factor (GEF) leading to the 
activation of Cdc42 and Rac-1, two small host Rho GTPases which stimulate 
cell actin cytoskeletal modifications. SipA performs the role of stabilising the 
actin filaments and promotes the extension of outward membrane ruffles 
whilst SipC nucleates actin and initiates polymerization, both leading to 
alteration of the cytoskeletal structure (Fàbrega & Vila, 2013; Zhang et al, 
2008). This alteration is further achieved by Salmonella’s mediation of 
phosphoinosides, leading to the increased elasticity of the plasma membrane 
(Zhang et al, 2008). Following Salmonella invasion, an additional SPI-1 
effector, SptP, performs as a GAP to inactivate Cdc42 and Rac1 and cause 
reformation of normal host-cell morphology (Zang et al, 2008). This process is 
not dissimilar to the process by which phagocytes engulf invading pathogens 
and results in the internalisation of Salmonella within the host cell (Pior et al, 
2009).  
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of S. typhi isolates from around the world indicate that they 
are highly related and that they emerged from a single point 
of origin approximately 30,000 to 50,000 years ago (11). 
Different strains may also harbor extrachromosomal DNA in 
the form of plasmids which usually carry virulence or 
antibiotic resistance genes (11).  
The genes for virulence factors cluster in pathogenicity 
islands (PI) after a foreign genome is integrated into the 
bacterial chromosome. Non-pathogenic related species of 
Salmonella do not have PIs. PI gene expression is generally 
limited to specific host compartments. They often “plug” in 
to endogenous two-component housekeeping regulators to 
“sense” where they are within a host and regulate expression 
accordingly (12). Two major PIs encode type three secretion 
system (TTSS) that translocates bacterial virulence proteins 
into host cells during infections (12) (Figure 1). 
The TTSS and its effectors encoded by Salmonella 
pathogenesis island 1 (SPI-1) are required for invasion of 
epithelial cells (12) and is activated under conditions thought 
to be present in the intestinal lumen before host cell invasion 
(13). The SPI-1 secreted effectors SopE and SopE2 act as 
guanine-nucleotide-exchange-factors (GEFs) for the small 
GTPases Cdc42 and Rac (14) (Figure 2). Additional SPI-1- 
translocated effectors of Salmonella affect actin dynamics 
during the invasion process. SipA binds and stabilizes actin 
and SipC, which forms part of the TTSS delivery pore, 
nucleates and bundles actin while anchored in the host cell 
membrane (15). Salmonella also alters the actin cytoskeleton, 
through manipulation of phosphoinositides. The plasma 
membrane is intimately associated with the actin cyto- 
skeleton, and this interaction depends on phosphatidylinositol 
4,5-bisphosphate (PtdIns(4,5)P2) (16). SigD/SopB is an SPI-1 
translocated inositol phosphatase that induces the rapid 
disappearance of PtdIns(4,5)P2 from invaginating regions of 
the membrane during Salmonella invasion. This increases 
elasticity to facilitate the remodelling of the plasma 
membrane associated with Salmonella entry (16). 
PtdIns(4,5)P2 has also been implicated in vesicle fission 
during the creation of phagosomes and clathrin-coated 
vesicles, and accordingly, SigD also is involved in sealing 
plasma membrane invaginations to form bona fide vacuoles 
(17). After invasion, an additional SPI-1 effector, SptP, acts 
as a GTPase-activating protein (GAP) for Cdc42 and Rac1, 
thereby inactivating these G proteins and returning cell 
morphology to a relatively normal state (17). SptP is a 
bifunctional protein, with its GAP domain at the amino 
terminus, and a protein tyrosine phosphatase domain at the 
carboxy terminus (18). A potential target for the tyrosine 
phosphatase activity of SptP is the intermediate filament 
protein vimentin, which is recruited to the membrane ruffles 
stimulated by Salmonella (18). Other studies have also 
identified another intermediate filament protein involved in 
Salmonella entry, SipC, which binds cytokeratins and 
expression of dominant negative cytokeratin-18 inhibits 
Salmonella entry into HEp2 cells (19) (Figure 2). Salmonella 
pathogenesis island 2 (SPI-2) encodes a second TTSS, 
effector proteins, molecular chaperones, and a two 
component regulatory system that activates SPI-2 promoters 
(14). This pathogenicity island and related effectors are 
required for intracellular survival and replication at systemic 
sites of infection. Furthermore, studies by Coombes and 
others have shown that negative regulation of SPI-2 is 
required for full typhoid pathogenesis and they (Coombes 
and others) have also identified a protein in Salmonella 
 
Figure 1. The TTSS is used by the bacteria to translocate 
virulence factors to the host during infections. Without it, 
invasion to host cells can not take place. 
 
 
 
 
Figure 2. Entry into host cells is mediated by the TTSS and its 
effectors encoded by SPI-1. Membrane attachment to the cortical 
actin cytoskeleton is loosened by SigD/SopB. SopE and SopE2 
enhance Cdc42 and Rac1 activity directly by acting as guanine-
nucleotide-exchange factors. SipA and SipC alter cytoskeletal 
structure, SipC by nucleating actin and initiating polymerization 
and SipA by binding actin and modulating actin bundling. These 
cytoskeletal rearrangements are downregulated by the GAP 
(GTPase-activating protein) activity of SptP, which inactivates 
Cdc42 and Rac. SigD also is involved in sealing invaginating 
regions of the plasma membrane to form intracellular vacuoles. 
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of S. typhi isolates from around the world indicate that they 
are highly related and that they emerged from a single point 
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Different strains may also harbor extrachromosomal DNA in 
the form of plasmids which usually carry virulence or 
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Figure 5:  The TTSS and effector proteins of Salmonella. (A) The 
type three secretion system (TTSS) of Salmonella encoded by SPI-1. 
This cylindrical, needle-like structure allows secretion of Salmonella 
effector invasion proteins into the host cell cytosol. (B) Effector 
proteins of SPI-1 in Salmonella interact with host cell mechanisms to 
cause alteration of the cell actin cytoskeleton and induce membrane 
ruffling, leadi g to the eventual engulfme  of the b teria in the cell 
(Figures taken from Zang et al, 2008). 
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1.3.1 Control of SPI-1  
Induction of SPI-1 and its components is controlled by the master regulator 
and activator, Hyperinvasion Locus protein A (HilA), which is also located on 
the SPI-1 locus. HilA is a member of the OmpR/ToxR family and its up-
regulation is vital for the expression of SPI-1 genes and therefore for 
Salmonella invasion to occur (Lucas & Lee et al, 2001; Baxter & Jones, 2015).  
Activation of HilA is controlled by a multi-component feed forward regulatory 
loop consisting of three AraC-like regulators, HilD, HilC and RtsA. All three of 
these regulators are capable of independently activating HilA expression 
(Srikanth et al, 2011) (Figure 6). Both HilD and HilC are required for hilA 
induction, even when multiple repressors are absent (Boddicker et al, 2002). 
These transcriptional activators are also located within SPI-1 and bind directly 
to promoter sequences upstream of hilA to induce its expression (Baxter & 
Jones, 2015). RtsA itself is encoded outside of SPI-1, though it works in 
concert with HilD and HilC in the feed-forward loop. HilD is also thought to 
activate HilA and rtsA expression by removing the repression of H-NS, a 
nucleoid-associated protein that inhibits the expression of SPI-1 (Martinez et 
al, 2014). HilA expression is negatively modulated by various additional 
factors, the most crucial of which is HilE. HilE exerts its effect by interacting 
with HilD and preventing it from activating hilA, therefore leading to SPI-1 
repression (Baxter & Jones, 2015). 
Following entry into the intestinal lumen Salmonella encounters the 
microenvironment of the intestinal epithelial cells, namely high pH, low oxygen 
and high osmolality. In these conditions, repression is completely removed as 
Salmonella enters the stationary phase and the expression of hilA is 
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accordingly induced (Queiroz et al, 2011). These individual environmental 
conditions are thought to act themselves as cues for the induction of HilA, 
leading in turn to the up regulation of SPI-1 and the secretion of effector 
proteins for host-cell invasion (Srikanth et al, 2011).   
 
Figure 6:  Control of the HilA transcriptional activator. HilA is a master 
regulator and transcriptional activator of SPI-1 genes in Salmonella and is 
itself controlled by a complex feed-forward loop. It is activated by three AraC-
like activators, HilD, RtsA and HilC and is repressed by the transcriptional 
repressor HilE and the global repressor H-NS (Figure taken from Fàbrega & 
Vila, 2013). 
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1.4 Salmonella and Reactive Nitrogen Species (RNS)  
Reactive Nitrogen Species (RNS) are the oxidized forms or adducts of 
nitrogenous products originally formed by nitric oxide synthases (Nathan & 
Shiloh, 2000).  Various RNS include nitric oxide (NO), nitrogen dioxide (NO2.), 
dinitrogen trioxide (N2O3) and peroxynitrite (ONOO-), all of which are 
encountered in physiological environments (Koskenkorva-Frank et al, 2013; 
Nathan & Shiloh, 2000).  RNS are capable of damaging lipids, proteins and 
DNA and are therefore under strict physiological regulation (Koskenkorva-
Frank et al, 2013).  
Many mammalian cell types produce RNS, often in response to inflammatory 
stimuli, the most notable of these being macrophages. Also produced by 
macrophages are reactive oxygen species (ROS), such as superoxide (O2.-), 
hydrogen peroxide (H2O2) and hydroxyl radicals (OH.), as by-products during 
mitochondrial electron transport or by the oxidation of various metabolites. 
The dismutation of O2.- forms H2O2, the latter of which can oxidize thiol groups 
and react with Fe(II) and Fe(III) to form other damaging compounds such as 
hydroxyl radicals (OH.) and hydroxide (OH-). Furthermore, both hydrogen 
peroxide and superoxide anions are capable of damaging iron-sulphur ([Fe-
S]) clusters (Arkenberg, 2013).  
NO can react with such ROS to form other RNS, for instance the production of 
O2.- and NO in macrophages is nearly equimolar, and the reaction of these 
two products results in the generation of ONOO- (Nathan & Shiloh, 2000). 
Other toxic intermediates produced by the reaction of RNS with ROS and their 
interactions are described in Figure 7.  
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Figure 7: Production and interactions of Reactive Oxygen Species 
(ROS) and Reactive Nitrogen Species (RNS). ROS and RNS are produced 
in mammalian cells by phagocyte oxidase (phox), also known as NADPH 
oxidase, and Nitric oxide synthase (iNOS) respectively. NO may react with 
superoxide (O2.-) to form peroxynitrite, a powerful oxidant and nitrating agent.  
NO may also be oxidized to nitrite (NO2-), which then can be oxidized to 
nitrogen dioxide (NO2) and this product may be oxidized further to nitrate 
(NO3-). ROS can produce superoxide (O2.-) which may under dismutation 
catalysed by superoxide dismutase (SOD) to become hydrogen peroxide 
(H2O2). Dissociation of H2O2 produces hydroxyl radicals (OH.) which can 
react with other volatile organic compounds to lose a hydrogen and form 
water (H2O) (Figure adapted from Fang, 2004). 
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NO a colourless gas containing an odd number of electrons, making it a 
radical with high reactivity (Kelm, 1999). It is produced at low concentrations 
during normal cellular metabolism and functions as a molecular messenger in 
eukaryotic cellular signalling (Koskenkorva-Frank et al, 2013; Park et al, 2011; 
Pacher et al, 2007). However, NO is also a potent cytotoxin lethal to most 
pathogens and thus also acts as an effector of the innate immune system 
(Arkenberg et al, 2011). As NO is a small, lipophilic free radical it is capable of 
diffusing freely in the cell and across bacterial membranes to exert 
bactericidal and bacteriostatic effects (Park et al, 2011; Atkan, 2004). 
Mammals unable to produce antimicrobial NO are significantly more 
susceptible to viral, fungal, parasitic and bacterial invasion (Richardson et al, 
2011). Notably, NO has been shown to be a critical component for controlling 
S. Typhimurium infection in murine models (Richardson et al, 2011). For 
instance, mice with abrogated iNOS alleles are more susceptible to infection 
with S. Typhimurium than control mice (Mastroeni et al, 2000). A 2002 study 
demonstrated that iNOS-deficient mice infected with an avirulent strain of 
Salmonella perished after 6 days due to severe septicaemia, which WT mice 
did not contract (Alam, 2002). Despite this, understanding of how NO and 
other RNS exert their bacteriostatic effects is limited and mechanisms of such 
action remains to be fully elucidated (Richardson et al, 2011; Park et al, 
2011).  Metabolic enzymes with essential redox centres comprised of protein 
thiols, Fe-S clusters or heme groups likely represent the major targets of NO-
mediated growth inhibition (Richardson et al, 2011; Cooper, 1999). Such 
cofactors are vital for various essential cellular processes such as electron 
transfer, nitrogen fixation and gene regulation. For example, FNR, Fur and 
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NsrR are all transcriptional regulators containing Fe-S clusters which may 
undergo nitrosylation, consequently inhibiting their DNA binding (Isabella et al, 
2009). NO has a high affinity for the terminal quinol cytochrome oxidases of 
the electron transport chain and can inhibit the ability of Salmonella to reduce 
O2 to H2O, resulting in respiratory arrest in nitrosatively stressed cells (Henard 
& Vazquez-Torres, 2011, Richardson, 2011). Many enzymes involved in 
glycolysis, fatty acid metabolism, glutamate biosynthesis and pyruvate 
catabolism consistently undergo thiol modification during nitrosative stress. 
Enzymes with [Fe-S] clusters are involved within the citric acid cycle and 
branched-chain amino acid biosynthesis and as a result of NO inhibiting such 
enzymes, Salmonella is unable to synthesise methionine or lysine during 
nitrosative stress (Richardson et al, 2011). NO can also react with the tyrosyl 
radical in the active site of ribonucleotide reductase. The nitrosylation of 
ribonucleotide reductase disrupts the formation of deoxyribonucleotides 
needed for repair and synthesis of DNA and may likely contribute to 
bacteriostatic effects of NO against Salmonella (Henard & Vázquez-Torres, 
2011). The indirect effects of NO on biological targets are mediated through 
the RNS generated from the reaction of NO with other molecules. NO is 
capable of reacting with superoxide anions (O2.-) or molecular oxygen (O2) in 
macrophages to form dinitrogen trioxide (N2O3), which is a potent oxidizing 
agent. Also in macrophages NO and the superoxide anion can combine to 
form highly reactive peroxynitrite (ONOO-), which is a powerful oxidant and 
nitrating agent and damages a wide array of molecules in cells including SH-
groups, lipids, DNA and proteins (Szabó, 2003; Prior et al, 2009). It can also 
react with carbon dioxide (CO2) to form nitrosoperoxocarbonate (ONOOCO2-) 
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which is highly reactive. Through oxidation or nitration mechanisms 
peroxynitrite can irreversibly inhibit mitochondrial respiration and damage a 
variety of mitochondrial components. It can therefore trigger cellular 
responses ranging from subtle modulations of cell signalling to overwhelming 
oxidative tissue damage, committing cells to necrosis or apoptosis (Virág, 
2002).  
NO is therefore a potent antimicrobial component of the innate immune 
system and plays a considerable role in the control of Salmonella infection. 
 
1.4.1 Nitric Oxide in the Gastrointestinal Tract  
As previously discussed, Salmonella is exposed to a range of RNS in the 
stomach and gut which act as a defence against infection (Henard & 
Vazquez-Torres, 2011). The majority of RNS present in the gastric lumen are 
from exogenous dietary sources. Nitrate is obtained from vegetables such as 
beets, celery and leafy greens in particular, whilst cured and processed meats 
can be a source of nitrite, which is added as a preservative (Prior et al, 2009).  
Concentrations of NO in the gastrointestinal tract therefore fluctuate from 
some 100µM to 500µM depending on dietary consumption of nitrate and 
nitrite (Prior et al, 2009; Henard & Vazquez-Torres, 2011). Commensal 
microbiota in the mouth first reduce dietary nitrate to nitrite, which is then 
protonated in the stomach to nitrous acid (HNO2). The disproportionation of 
HNO2 forms various RNS including NO, NO2 and N2O3 (Henard & Vazquez-
Torres, 2011). At low pH conditions, such as those encountered in the 
stomach, RNS have direct bactericidal effect against Salmonella. At slightly 
higher pH RNS can have indirect antimicrobial activity, such as interfering with 
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the acid tolerance response of Salmonella that allows it to survive strongly 
acidic conditions (Henard & Vazquez-Torres, 2011).  
 
1.4.2 Nitric Oxide in Macrophages  
Macrophages are mononuclear phagocytic leukocytes which have key roles in 
both innate and adaptive immunity (Prior et al, 2009). Some may be located in 
specific tissues, such as Kupffer cells in the liver, whilst others circulate in the 
blood plasma and are then recruited to sites of infection (Prior et al, 2009). 
They are an essential part of the immune response to invading pathogens and 
their ability to produce NO is vital for controlling Salmonella infection (Prior et 
al, 2009). NO is produced in the body by nitric oxide synthases (NOSs) of 
which there are three known isoforms (Aktan, 2004). These include epithelial 
nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNos) and 
inducible nitric oxide synthase (iNOS) (Aktan, 2004). In macrophages NO is 
produced by iNOS which catalyses the conversion of L-arginine and 
molecular oxygen to L-citrulline and NO as part of the innate immune 
response (Aktan, 2004). In contrast to eNOS and nNOS, iNOS is able to 
generate NO without the need for elevated intracellular calcium (Ca2+) 
(Chakravortty & Hensel, 2003). As high levels of NO are cytotoxic to host-cells 
as well as pathogens, iNOS activation is highly regulated in order to prevent 
overproduction of NO (Atkan, 2004). Unlike eNOS and nNOS which are 
constitutively present and active in resting cells, expression of iNOS is low in 
macrophages before its transcription is up-regulated by immunostimulatory 
cytokines and PAMPS (Cherayil & Antos, 2001). The lipopolysaccharide 
(LPS) component of the cell wall of Salmonella is one such molecule. LPS is 
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bound by the LPS-binding protein (LBP) which transports it to a receptor with 
high affinity for the LPS molecule, known as CD14. This LPS-CD14 complex 
interacts with TLR4 and associated small extracellular MD-2 protein to 
activate an intracellular signalling cascade via adaptors such as IRAK and 
MyD88. Ultimately this results in the activation of the NFκβ signalling 
pathway, which activates transcription of iNOS in the nucleus (Lowenstein & 
Padalko, 2004). Inflammatory cytokines such as tumour necrosis factor alpha 
(TNF-α) and interleukin 1β (IL-β), which are produced by infected host cells, 
and Interferon-γ (IFN-γ), produced by activated immune cells, can also 
activate iNOS expression (Cherayil et al, 2000; Lowenstein & Padalko, 2004). 
IFN-gamma signalling results in dimerization of JAK proteins and 
subsequently leads to phosphorylation and translocation of a STAT protein to 
the nucleus to increase expression of IRF-1 transcription factor. This 
transcription factor binds to the iNOS promoter in the nucleus and causes up-
regulation of iNOS gene expression (Prior et al, 2009). Similarly, SPI-1 
effectors can stimulate the formation of inflammasomes and activation of IL-Iβ 
and IL-18. Caspase-1 has also been shown to be able to induce the 
expression of iNOS and lead to production of NO (Henard & Vazquez-Torres, 
2011; Buzzo et al, 2010).   
As well as NO, macrophages also produce ROS, enabling them to bombard 
Salmonella with so-called respiratory bursts. When activated a 
multicomponent nicotinamide adenine dinucleotide phosphate reduced 
(NADPH) oxidase is responsible for catalysing the reduction of molecular 
oxygen to superoxide. This radical is then able to combine with other oxygen 
species for form more toxic ROS such as hydrogen peroxide and hydroxyl 
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radicals (Forman & Torres, 2002; Vazques-Torres & Fang, 2001). The 
respiratory burst plays a powerful role in innate defence; those individuals 
lacking functional NADPH oxidase are prone to recurring and severe bacterial 
and fungal infections (Fang & Vaquez-Torres, 2002). The NADPH oxidase in 
phagocytes is NADPH oxidase 2, or NOX2, and is assembled at the plasma 
membrane. In resting cells, the membrane-bound and cytosolic components 
of the enzyme are separated by vesicles and only come together when the 
enzyme is activated by various stimuli. Such stimuli include arachidonic acid, 
phospholipases A and D and protein kinase C. Activation leads to cytosolic 
components migrating to the plasma membrane to assemble to form the 
active NADPH oxidase enzymatic complex (Vazquez-Torres & Fang, 2001). 
Together with iNOS, the respective oxidative and nitrosative bursts produced 
by these enzymes play a critical role in the killing of Salmonella inside 
macrophages. 
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Figure 8: Activation of iNOS and production of NO inside macrophages. 
PAMPS such as LPS and immunostimmulatory cytokines such as Interferon-γ 
(INF-γ) produced by activated immune cells are capable of activating iNOS 
expression. IFN-γ signalling leads to JAK-STAT signalling which ultimately 
increases the expression of the IRF-1 transcription factor. IFR-1 binds to the 
iNOS gene promoter region in the nucleus and causes up-regulation of iNOS 
gene expression. The LPS component of Salmonella is detected by TLR4 
which induces an NF-κB pathway leading to activation of iNOS transcription in 
the nucleus. Once active, iNOS catalyses the reaction of L-arginine and 
molecular oxygen to produce L-citrulline and NO. NO may exert bacteriostatic 
effects on Salmonella and it may also join with superoxide produced by 
NADPH oxidase to form the highly oxidative and nitrosative peroxynitrate 
(ONOO-). Superoxide may also spontaneously form hydrogen peroxide (H2O2) 
which damages Salmonella through oxidative stress, or may undergo further 
reactions to generate other ROS. (Figure adapted from Lowenstein & Padalko, 
2004.) 
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1.4.3 Nitric Oxide in Salmonella Nitrate Catabolism 
Salmonella is a facultative anaerobe, meaning that whilst it preferentially 
utilizes oxygen as an energy source, in low oxygen conditions it is able to 
switch to nitrate metabolism, a process known as denitrification (Arkenberg et 
al, 2011). This process involves the use of nitrate reductase systems that will 
be discussed later. Whilst in most soil bacteria nitrate is ultimately converted 
to N2, both Salmonella and E. coli undergo truncated denitrification, where 
nitrate is converted into nitrous oxide (N2O) via nitrite and NO (Arkenberg et 
al, 2011). This is due to it lacking the nitrous oxide reductase (NosZ), which 
converts N2O into N2. The result being that when nitrate is used as an 
alternative electron acceptor NO is produced a toxic intermediate which 
Salmonella must be able to detoxify to survive. 
 
1.5 Nitric Oxide Detoxification  
Salmonella survival relies on the bacteria having some mechanism by which 
to detoxify the endogenous and exogenous NO it encounters.  Three 
metalloenzymes are well-characterized for their involvement in NO 
detoxification in Salmonella, including the cytochrome c nitrite reductase 
(nrfA), flavorubredoxin (norV) and flavohemoglobin (hmpA). These three 
enzymes operate under different oxygen conditions (Prior et al, 2009) (Figure 
9).  
 
1.5.1 Cytochrome c nitrite reductase  
Cytochrome c nitrite reductase (NrfA) is an anaerobic respiratory enzyme 
which is expressed in the presence of nitrate and only under anoxic or micro-
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oxic conditions. When active it is able to reduce either NO2 or NO to 
ammonium (NH4) (Prior et al, 2009). NrfA is a multihaem, periplasmic protein 
which appears to be most active as a NO reductase in acidic conditions (van 
Wonderen et al, 2008). It might therefore play a role in NO detoxification in the 
micro-oxic and very acidic contains of the stomach, where there is a high 
disproportionation of nitrate to NO (Prior et al, 2009).  However, NrfA does not 
seem to be required for Salmonella survival in mice (Prior et al, 2009). 
 
1.5.2 Flavorubredoxin 
Flavorubredoxin (NorV) is an oxygen sensitive NO reductase with an 
associated oxidoreductase (NorW) (Mills et al, 2005).  It is active under 
anaerobic or low-oxygen conditions where it reduces NO to nitrous oxide 
(N2O). The transcriptional activator NorR senses NO levels and induces 
transcription of norV (Prior et al, 2009).  It has been well studied in both E. coli 
and Salmonella and does not appear to be necessary for E. coli survival in 
murine macrophages or for Salmonella survival in mice (Prior et al, 2009).  
 
1.5.3 Flavohemoglobin  
The flavohemoglobin (HmpA) consists of an N-terminal heme group and C-
terminal reductase and is active under both anaerobic and aerobic conditions. 
In aerobic environments HmpA oxidises NO to NO3, whilst in anaerobic 
environments it reduces NO to N2O. Though its precise significance under 
anaerobic conditions remains to be elucidated, it is known to be the major 
enzyme responsible for aerobic NO metabolism (Prior et al, 2009; Bang et al, 
2006).  The expression of hmpA is induced by NO and repressed by the 
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presence of intracellular iron (Prior et al, 2009). It is also repressed in the 
absence of NO, by the nitric oxide sensitive repressor (NsrR). NsrR is a 
member of the Rrf2 family of transcriptional factors and contains an iron-sulfur 
(Fe-S) cluster which is necessary for NsrR to bind DNA and repress hmpA 
expression. NO is capable of nitrosylation of the Fe-S cluster, which 
abrogates the ability of NsrR to bind DNA and therefore lifts repression of 
hmpA (Karlinsey et al, 2012). The NsrR regulon is now known to include hcp-
hcr, yeaR-yoaG, ygbA, ytfE and STM1808, as well as hmpA (Karlinsey et al, 
2012). Studies have shown that hmpA expression is highly induced in 
macrophages, suggesting that it plays a vital role in detoxification of NO 
produced by iNOS (Eriksson et al, 2003). By contrast, it is not induced in 
epithelial cells, where Salmonella is not exposed to either oxidative or 
nitrosative stress (Hautefort et al, 2008).  
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Figure 9: Pathways of Nitrate Catabolism and Nitric Oxide detoxification in 
Salmonella.  NO is produced endogenously as a by-product of Salmonella 
denitrification, where Salmonella utilises nitrate as an alterative electron acceptor 
under anaerobic conditions.  As part of this process two distinct nitrate reductase 
systems are utilised, the membrane bound NarGHJI and the periplasmic NapA. In 
the cytoplasm NarG reduces nitrate to nitrite, which is then further reduced to NH4 
by the sirohaem-containing nitirite reductase (NirB). In the periplasm nitrate is 
reduced to nitrite by NapA, and further reduced to NH4 by the cytochrome c nitrite 
reductase (NrfA). Detoxification of both endogenously and exogenously produced 
NO is carried out by three main enzymes; flavohaemoglobin (HmpA), 
flavorubedoxin and associated oxidoreductase (NorVW) and Cytochrome c nitrite 
reductase (NrfA.) NorVW and NrfA are only active under anaerobic or micro-oxic 
conditions. HmpA has only a minor role in NO detoxification under anoxic 
conditions, but is the crucial enzyme when oxygen is present. NrfA reduces nitrite 
or NO to NH4, NorV reduces NO to N2O and HmpA oxidizes NO to NO3 (oxic 
conditions) or reduces NO to N2O (anoxic conditions). (Figure taken from Prior et 
al, 2009.)  
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1.6 Nitrate Reductase Systems  
As previously discussed, Salmonella is capable of using nitrate (NO3) as an 
alternative electron acceptor when oxygen is unavailable. In order to 
accomplish this reaction Salmonella synthesizes two biochemically distinct 
nitrate reductases, a membrane-bound system (NarGHI) and a periplasmic 
system (NapA) (Rowley et al, 2012). These two systems have corresponding 
nitrite reductases which further reduce the NO2 to NH4 in the cytoplasm and 
periplasm respectively.  The NarG system was the first nitrate reductase 
system identified in Salmonella and is expressed under high nitrate 
concentrations (Prior et al, 2009). NarG reduces NO3 to NO2 in the cytoplasm 
(reaction 1) and this NO2 is further reduced to NH4 by a sirohaem-containing 
nitrite reductase (NirB) (reaction 2). 
 
Reaction 1: NO−3 +2e
−+2H+ →NO−2 +H2O   
Reaction 2: NO−2 + 6e
− + 8H+ → NH+4 + 2H2 O  
 
NapABC is the periplasmic nitrate reductase encoded by the NapFDAGHBC 
(NapF) operon which was more recently identified. NapA is the catalytic 
subunit which reduces NO3 to NO2 in the periplasm (Dow et al, 2014) 
(reaction 1). The periplasmic cytochrome c nitrite reductase (NrfA) then 
reduces this NO2 to NH4 (reaction 2) (Rowley et al, 2012). This process, 
which produces extracellular NH4, is known as dissimlatory nitrate reduction 
to ammonium (DNRA) (Rowley et al, 2012). NO is produced as a toxic 
intermediate to these reactions and must be detoxified by the mechanisms 
described above. Because of its location in the periplasm, it is possible that 
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NapA performs the initial step in nitrate reduction (Rowley et al, 2012). 
However, in high nitrate conditions NarG acts as the main nitrate reductase, 
for instance when active in E. coli under high nitrate conditions it performs 
98% of nitrate reductase activity (Rowley et al, 2009).  NapA, which is 
repressed in the presence of oxygen, may conversely be the main nitrate 
reductase under nitrate-limited conditions. Whilst NarG is energy efficient, it 
has low-affinity for nitrate, whereas NapA has a high affinity for nitrate though 
it is less energy efficient. Therefore, when nitrate is scarce, NapA provides a 
higher affinity, though more poorly-coupled pathway for nitrate reduction 
(Rowley et al, 2012).  
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Figure 10: Salmonella denitrification enzymes and pathways of nitrate 
reduction. Salmonella is capable of utilising NO3 as an alternative electron 
acceptor in a process called truncated denitrification by which it is ultimately 
reduced to N2O. This process utilises either of two nitrate reductases systems, 
NarGHI (membrane-bound) or NapA (periplasmic) depending on nitrate conditions. 
The NarZYWV system is thought to be an isozyme of NarG expressed under 
aerobic growth, whilst NarG is expressed and predominately active under 
anaerobic conditions. Antiporters such as NarK and NirC transport NO3, NO2 and 
protons across the periplasmic membrane. In the cytoplasm NarG reduces NO3 to 
NO2 that is then reduced to NH4 by NirB. Conversely, Nap in converts NO3 to NO2 
in the periplasm, and the periplasmic cytochrome c nitrite reductase (NrfA) then 
reduces this NO2 to NH4. The reduction of this NO3 by nitrate reductases such as 
NarG, it’s isozyme, NarZ or NapA and their associated nitrite reductases provides 
energy for the bacterial cell and produces endogenous NO as a by product. NarG 
appears to be the main nitrate reductase system active under high nitrate 
conditions, whilst NapA may become predominately active under nitrate-limited 
conditions. (Figure adapted from Prior et al, 2009.) 
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1.7 Context and Aims  
Members of the Salmonella genus are successful enteric pathogens that 
cause gastroenteritis and Typhoid Fever in humans. Salmonella infections are 
thought to be associated with some 1 million deaths per year worldwide and 
therefore are a significant burden on global health (Prior et al, 2009). 
Currently, two typhoid vaccines are internationally available, one of these 
being Ty21a, a live, oral typhoid vaccine consisting of an attenuated strain of 
S. Typhi. The other is a component vaccine formed from the purified capsular 
polysaccharide S. Typhi Vi antigen (Cheminay & Hensel, 2008; Thiem et al, 
2011). Both are currently licensed for use against Typhoid and have been 
shown to successfully immunise against Typhoid fever (Garmory et al, 2002). 
However, these vaccines have limited efficiency and require frequent boosters 
(Anwar et al, 2014). Due to their shortfalls, these vaccines are ineffective at 
controlling Typhoid in regions where the disease is endemic and instead are 
mostly utilized as ‘Traveller’s Vaccines’ for individuals from predominately 
high-income countries (Anwar et al, 2014). An efficient vaccine that controls 
the disease in Typhoid epidemic countries is, as yet, non-existent, and greatly 
needed (Anwar, et al, 2014).  A further worrying issue is the development of 
antibiotic resistance in Salmonella, with genetic and genomic evolution 
leading to increasingly virulent and antibiotic-resistance strains (Onwuezobe 
et al, 2012; Hurley et al, 2014). Since the 1970s S. Typhi strains have shown 
resistance to ampicillin, choramphenicol and co-trimoxazole; three primary 
antibiotics (Wong et al, 2015). Furthermore, resistance to fluoroquinolone, 
used as an alternative since the 1990s, has been described in various parts of 
Asia (Bhutta et al, 2006). Moreover, this multidrug resistant typhoid appears to 
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result in more severe manifestations of the disease, with higher rates of 
complications and fatalities (Bhutta et al, 1996).  A recent study in Nature 
genetics identified a MDR S. Typhi clade of Salmonella, H58, present in Asia 
and Africa, which is outcompeting the antibiotic-sensitive S. Typhi strain 
population. The study claims H58, ensuing from the overuse of antibiotics, 
appears to be causing MDR outbreaks of Typhoid in previously unaffected 
areas and identify it as a threat to global health (Wong et al, 2015).  There 
have also been reports of NTS resistance to fluroquinolones, third-generation 
cephalosporins and possibly also carbapenem, particularly after the increase 
in the use of antibiotics for treating NTS in livestock (Hurley et al, 2014; 
Onwuezobe et al, 2012; Tatavarthy et al, 2014). Within the last century multi-
drug resistant strains of Typhimurium have emerged and been associated 
with higher mortality and morbidity rates (Onwuezobe et al, 2012). In fact, 
more than 55% of Typhimurium isolates show multidrug resistance and 
strains which are resistant to ampicillin, chloramphenicol, streptomycin-
spectinomycin, sulphonamides and tetracyclines have been reported in Spain 
and the UK and are also likely present in other European Countries 
(Kirkpatrick et al, 2005; Fàbrega & Vila, 2013; Weill et al, 2006; Cloeckert & 
Schwarz, 2001). A further worrying development has been the ermergence of 
an invasive-NTS strain of Salmonella (iNTS) in Africa, ST13, which also 
shows multidrug-resistance (Morpeth et al, 2009; Feasey et al, 2012). 
Currently there are no vaccines for NTS (Wick, 2011). 
It is vital that new therapeutic targets are discovered in Salmonella in order to 
facilitate the creation of a new generation of effective antimicrobials and 
vaccines. Necessary for this is a thorough understanding of Salmonella 
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physiology and pathogenic mechanisms. Building on preliminary data from the 
Rowley lab, this study aims to characterize and investigate various genes, 
which may potentially be involved in the detoxification of NO in Salmonella 
and therefore aid Salmonella survival in the host. A further aim of this 
research is to determine whether the transcriptional activator HilA regulates 
the Nap nitrate reductase of Salmonella. This could have significant 
implications if Nap is otherwise involved in Salmonella colonisation and 
invasion of the host intestine. 
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CHAPTER 2: MATERIALS AND METHODS 
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2 Materials and Methods 
2.1 Materials 
All chemicals and reagents were obtained from Sigma Aldrich (UK) or Fisher 
Scientific (UK) unless otherwise specified. Where necessary solutions and 
media were made using dH2O, exempting those used for RNA work, which 
were prepared using nuclease and protease-free molecular biology grade 
water (Sigma, W4502). This will hereon be referred to as ‘Sigma Water’.   
 
2.2 Bacterial Strains and Plasmids 
The bacterial strain studied in this work was the isogenic, parental strain 
Salmonella enterica serovar Typhimurium SL1344 described by Hoiseth & 
Stocker, 1981. All mutagenic strains utilised in this study derive from this wild-
type (WT) strain. Table 1 lists all bacterial strains used in this study, all 
plasmids used may be found in Table 2.  
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Table 1: Bacterial strains used  
Strain Genotype Reference 
 
SL1344 
 
S.Typhimurium WT, His- 
 
Hoiseth & 
Stocker, 
1981 
∆STM1250 SL1344 ∆STM1250::kan This study 
∆STM1250 SL1344 ∆STM1250::cat This study 
∆STM4552 SL1344 ∆STM4552::kan This study 
∆STM4552 SL1344 ∆STM4552::cat This study 
∆STM1586 SL1344 ∆STM1586::kan This study 
∆STM3362 SL1344 ∆STM3362::kan Arkenberg 
∆ycfR SL1344 ∆ycfR::kan Arkenberg 
∆ycfR SL1344 ∆ycfR::cat This study 
∆ybiJ SL1344 ∆ybiJ::kan Arkenberg 
ΔSTM3362 ∆ycfR SL1344 ΔSTM3362::kan, ∆ycfR::cat This study 
∆STM3362- ∆ycfR ∆ybiJ SL1344 ΔSTM3362::kan, ∆ycfR::cat, 
∆ybiJ::kan 
This study 
ΔIbpA ∆IbpB SL1344 ΔIbpA ∆IbpB::kan This study 
ΔSTM1250 ∆STM251 SL1344 ∆STM1250::kan, ∆STM1251::kan This study 
ΔSTM1250 ∆STM1251 SL1344 ∆STM1250::cat, ∆STM1251::cat This study 
∆STM1250 ∆STM121 ∆IbpA ∆IbpB SL1344 ΔIbpA ∆IbpB::kan, 
∆STM1250::cm, ∆STM1251::cm 
This study 
∆SL1344 SL1344:pMP220 Prior, 2011 
∆SL1344 SL1344∆hilA:pMP220 Prior, 2011 
∆SL1344 SL1344:pMP220:napF Prior, 2011 
∆SL1344 SL1344∆hilA:pMP220:napF   Prior, 2011 
∆STM1808∆tehB ∆yeaR ∆hmpA SL1344∆STM1808::cat,∆tehB ∆yeaR 
∆hmpA::kan 
 
Johnson 
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Table 2: Plasmids used  
 
2.3 Bacterial Culture Conditions 
2.3.1 Media 
All media was sterilized by autoclaving for a duration of 15 minutes at 121°C 
prior to use. Where necessary media was also supplemented with appropriate 
antibiotic(s), concentrations of which may be found in the ensuing section.  
 
Luria Bertani (LB) Miller Broth (per L) (Bertani, 1951)  
10g Tryptone 
5.0g Yeast Extract 
10.0g NaCl.  
Solution was made up to 1L by addition of dH2O and autoclaved. 
 
Plasmid Genotype Source 
 
pcP20 
 
Temperature-sensitive replication and 
thermal induction of FLP synthesis, 
AmpR, CatR 
 
Cherepanov & Wackernagel, 
1995 
pkD3 AmpR, pANT-Sɣ derivative containing 
a FRT-flanked CmR 
Datsenko & Wanner, 2000 
pkD4 AmpR, pANT-Sɣ derivative containing 
a FRT-flanked KanR 
Datsenko & Wanner, 2000 
pkD46 AmpR, pINT-ts derivative containing 
araC-ParaB and ɣ, β, exo genes 
Datsenko & Wanner, 2000 
pMP220 Wide host-range promoterless-lacZ 
probe vector (TetR), low-copy number 
Zaat et al., 1987 
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Luria Bertani High Salt (LBS) Miller Broth (per L)   
10g Tryptone 
5.0g Yeast Extract 
17.7g NaCl.  
Solution was made up to 1L by addition of dH2O and autoclaved. 
 
Luria Bertani (LB) Agar (per L) 
10g Tryptone 
5.0g Yeast Extract 
10.0g NaCl. 
1.5% Agar  
LB was prepared as described above. 200mL aliquots of this solution were 
divided into 500mL conical flasks containing 3g of 1.5% agar prior to 
autoclaving.  
 
Lennox Broth (per L) 
10g Tryptone 
5.0g Yeast Extract 
5g NaCl 
Solution was made up to 1L by addition of dH2O and autoclaved. 
  
Green LB Agar (per L) (Maloy et al., 1996) 
8g Tryptone 
1g Yeast Extract 
5g NaCL 
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Dissolved in 950mL dH2O. 190mL aliquots of this solution were added to 
500mL conical flasks containing 3g of 1.5% agar. Subsequent to autoclaving 
the following solutions were added:  
 21 mL (4mL per flask) 40% glucose (autoclaved) 
 25 mL (5mL per flask) 2.5% alizarin yellow G (autoclaved; heated until 
molten)  
 3.3 mL (0.65mL per flask) 2% aniline blue (filter sterilized) 
 
M9 Minimal Media  
M9 minimal media was prepared as follows.  
33.91g  Na2HPO4, 
15g KH2PO4 
 2.5g NaCl 
5g NH4Cl  
Dissolved in 400mL dH2O and autoclaved. This solution was then 
supplemented with the following: 
30µg/1mL of Histidine 
1µL/mL of 1M CaCl 
20µl/mL MgSO4. 
2.5mL or 10mL of 1M NaNO3  
2.5mL or 10mL 1M Glycerol  
 
2.3.2 Reagents  
Z-Buffer  
6.02mL Na2HPO4.7H2O (0.06M) 
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4mL NaH2PO4.H2O (0.04M) 
1mL 1M KCl (0.01M) 
0.1mL 1M MgSO4 (0.001M) 
0.175mL β-mercaptoethanol (BME) (0.05M) 
Make up to 50mL with H2O.  
 
O-nitrophenol-β-D-galactopyranoside (ONPG)  
4mg/ml ONPG was prepared by dissolving 0.012mg of O-nitrophenol-β-D-
galactopyranoside in 3ml of phosphate buffer. 
 
2.3.3 Antibiotic Stock  
Antibiotic stocks were prepared to the following concentrations and stored in 
1mL aliquots at 4°C. For tretracycline and chloramphenicol concentrations 
were achieved by dilution in ethanol instead of water.  
 
Ampicillin     100μg mL-1  Filter sterilized  
Kanamycin    50μg mL-1  Filter sterilized  
Chloramphenicol     10μg mL-1 
Streptomycin    100μg mL-1  Filter Sterilized  
Tetracycline     5μg mL-1 
 
2.3.4 Overnight Culture 
Using aseptic technique bacterial strains were streaked for single colonies on 
Luria-Bertani (LB) agar plates supplemented with appropriate antibiotic(s). 
Subsequent to streaking plates were incubated statically at 37°C overnight for 
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growth. Bacterial plates were stored at 4°C and used for a maximum of 10 
days. Overnight cultures consisted of 10mL LB media supplemented with 
10μL of appropriate antibiotic and inoculated with a single bacterial colony. 
These were incubated overnight at 37°C with shaking at 200 rpm.  
 
2.3.5 Freezer stocks 
Freezer stocks of bacterial strains were created and stored at -80°C using 
MicrobankTM beads (ProLab Diagnostics) according to manufacturers 
instructions.  
 
2.4 Polymerase Chain Reaction (PCR) 
PCR was performed in a Thermocycler as per the program listed in Table 3. 
Elongation time was adjusted following the general rule of one minute per 
kilobase-pair (kb). Where necessary annealing temperature was optimised to 
5°C below primer Tm. Conditions of PCR are described in Table 4. 
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 Table 3: PCR Reaction Components 
Reagent Mutagenesis PCR [μL] Verification PCR [μL] 
Forward Primer (3’-5’) 1 0.5 
Reverse Primer (5’-3’) 1 0.5 
Template DNA 5 5 
Sigma Water 189 6.5 
BIOMIX (Bioline) 2X 25 23.5 
Total volume  50 25 
  
 
Table 4:  PCR Programme Details  
Programme Stage Temperature [°C] Time 
1) Initial Denaturation 96°C 3 minutes 
2) Denaturation 96°C 3 minutes 
3) Annealing 55°C* 30 seconds 
4) Elongation 72°C* 1.30 seconds 
5) Repeat steps 2-4 29 X  
6 Final Elongation 72 °C 4 minutes 
*Annealing temperature was altered depending on the Tm of primer sequences. *Elongation time was 
adjusted to at least 1-minute per kb of PCR product. 	
	 69	
2.4.1 Colony PCR 
To obtain chromosomal DNA a single bacterial colony was taken from a 
freshly streaked plate and resuspeded in 100μL of Sigma Water by vortexing. 
Subsequent solutions were boiled for 5 minutes at 100°C to lyse the cell 
before centrifugation for 2 minutes at 14600 rpm. 5μL of the resultant 
supernatant was used as template DNA.  
 
2.4.2 PCR product purification (Miniprep) 
PCR products were purified using a QIAquick PCR Purification KitTM (Qiagen) 
as per manufacturers instructions to eliminate excess PCR reaction reagents. 
DNA was bound to a centrifuge column by the mixture of PCR sample with 
binding buffer (PB) in a respective 1:5 volume. Following 1-minute 
centrifugation at 13,000 rpm and removal of the eluted supernatant, 0.75mL of 
PE buffer was added and the column centrifuged for a further minute before 
the supernatant was again discarded. Purified DNA was eluted by the addition 
of 50μL of Sigma Water to the column. Concentration of the purified product 
was determined by Nanodrop analysis and purified DNA stored at -20°C.  
 
2.5 Plasmid purification (Miniprep) 
Plasmid purification was achieved by use of a QIAprep Spin Miniprep Kit 
(Qiagen) according to manufactures instructions. Bacteria containing the 
desired plasmid were streaked for single colonies on an agar plate containing 
appropriate antibiotic. The following day 10mL LB supplemented with 10μl of 
appropriate antibiotic was inoculated with a single colony and grown 
overnight. 1mL of this culture was centrifuged at 14,000 rpm for 1 minute at 
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room temperature. The supernatant was discarded and the pellet 
resuspended in residual solution before a further 1ml of culture was added 
and the processes repeated. Once a sizeable pellet was achieved it was 
resuspended in 500μL of Buffer P1, mixed and 500μL of P2 buffer added. 
700μL of buffer N3 was subsequently added and the solution centrifuged for 
10 minutes at 13,000 rpm, after which the supernatant was applied to a 
centrifuge column. This column was then centrifuged and flow-through 
discarded before the column was washed and spun with 500ul PB buffer and 
750μL PE buffer respectively. 50μL of Sigma Water was then applied to the 
column to elute the DNA. 
 
2.6 Green Plates 
Green plates containing a pH specific dye were used in the identification of 
true-lysogens and differentiation from pseudo-lysogens following phage 
transduction. Plates were prepared according to Maloy et al., 1996. Briefly, 
green agar was prepared using 8g Tryptone, 1g Yeast Extract, 5g NaCL with 
1.5% (w/v) agar per 1 L dH2O and autoclaved. 21mL of 40% (w/v) glucose 
(F/S), 25mL of 2.5% (w/v) alizarin yellow G and 3.3 mL of 2% (w/v) aniline 
blue (f/s) were added following autoclaving. Appropriate antibiotic was added 
if necessary. True-lysogens were identified on green plates by their light 
green colour.    
  
2.7 Bacterial Growth Curves and Spectrophotometry 
Bacterial growth curves were performed in 250mL conical flasks containing 
50mL of LB broth. Flasks were inoculated with aliquots of LB overnight culture 
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normalized to an OD of 0.02 at 600nm and grown for 8 hours at 37°C, 200 
rpm. 1mL of culture was taken from flasks at 1-hour intervals and transferred 
to a 1.5mL plastic cuvette by aseptic technique. The optical density of culture 
samples at 600nm (OD600) was measured in a spectrophotometer (Molecular 
Devices, SpextraMax M5) using 1mL of sterile LB as a reference. Once 
cultures had reached an OD600 exceeding 1.0 1mL samples were diluted in a 
1:10 ratio with sterile LB. Following 8 hours of growth, cultures were incubated 
overnight and a further measurement taken at 24 hours.   
 
2.8 Agarose gel electrophoresis 
Agarose gels were prepared for the separation and visualisation of PCR 
products as follows; 10x TBE buffer (106g Tris base, 55 g boric acid, 40mL 
EDTA, made up to 1L with dH2O) was diluted 1:10 to form a 1 x TBE buffer 
solution. 
The gel was prepared by adding 1% agarose (w/v) to 1x TBE solution in a 
conical flask which was then microwaved until agarose was fully dissolved.   
Once cool, 0.04% (v/v) Ethidium Bromide was added to the agarose solution 
and mixed. The solution was then poured into a gel cast with comb and left to 
solidify at room temperature. The comb was then removed and the gel placed 
in an electrophoresis tank (Sub-cell GT, BIO-RAD)   
 
2.9 Mutant Construction 
2.9.1 Mutagenesis via Phage- λ Red Recombination  
De novo mutagenesis was performed using the λ Red Recombination system 
to replace chromosomal genes of interest (GOI) in the S. Typhimurium strain 
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SL1344 with antibiotic resistant cassettes. Briefly, this technique utilizes three 
phage-λ Red proteins, γ (Gam), exo (Exo) and β (Beta) to recombine linear 
DNA containing short homologies with appropriate target sequences. γ 
prevents E. coli nucleases from degrading the linear double-stranded DNA 
(dsDNA) whilst Exo degrades this dsDNA to leave single-standed DNA that β 
may then bind to and facilitate recombination via annealing to the homologous 
genomic target site (Mosberg et al, 2010; Sawitzke et al, 2007).  
Plasmid DNA encoding resistance cassettes for either chloramphenicol 
(pKD3) or kanamycin (pKD4) were amplified via PCR. Amplification was 
achieved using the PCR protocol described in Table 4, with primers listed in 
Table 5. Primers contained a 5’ 40bp sequence homologous to regions 
upstream or downstream of the GOI linked to a 3’ sequence homologous for 
the antibiotic resistance cassette to be amplified. This process is shown in 
Figure 11. The resultant linear PCR product with henceforth be referred to as 
the mutant construct and was PCR purified in preparation for electrophoresis. 
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Figure 11: Mutant construction via Lambda Red Recombineering 
H1 and H2 = Homology regions 
P1 and P2 = Priming sites 
1. Antibiotic cassettes amplified by PCR from pKD3 or pKD4  
2. Resultant PCR products electroporated into the SL1344 containing 
pKD46. 
3. Chloramphenicol and kanamycin resistant colonies identified via plating 
on antibiotic plates. 
4. Mutants transduced into a clean S. Typhimurium SL1344 background to 
avoid further recombination events. Loss of the targeted gene was 
confirmed by PCR.  
(Figure adapted from Datsenko & Wanner, 2000).  
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Figure 11: Mutant construction via Lambda Red Recombineering 
H1 and H2 = Homology regions 
P1 and P2 = Priming sites 
1. Antibiotic cassettes amplified by PCR from pKD3 or pKD4  
2. Resultant PCR products electroporated into the SL1344 containing 
pKD46. 
3. Chloramphenicol and kanamycin resistant colonies identified via 
plating on antibiotic plates. 
4. Mutants transduced into a clean S. Typhimurium SL1344 background 
to avoid further recombination events. Loss of the targeted gene was 
confirmed by PCR.  
 
	 74	
2.9.2 Electroporation 
Electrocompetent cells were prepared of the WT strain SL1344 containing the 
temperature sensitive plasmid pKD46, which encodes the phage λ red 
recombination proteins. A single colony of SL1344 pkD46 was grown 
overnight at 30°C in 10mL LB broth containing 10μL ampicillin. A 1:100 
dilution of this overnight was used to inoculate 50mL of Lennox Broth 
supplemented with 50μL Ampicillin and 50μL 1mM L-arabinose. This culture 
was then incubated at 30°C until it reached an OD600 of 0.6 at which point it 
was transferred into a falcon tube and centrifuged for 15 minutes at 4000 rpm, 
4°C. The resultant pellet was re-suspended in 25μL of 10% (v/v) ice-cold 
glycerol before centrifugation and washing was repeated twice more. Cells 
were kept cold throughout this process to preserve their competency. 
Subsequent to the final wash, the pellet was resuspended in residual 10% 
glycerol. Solution containing the resuspended pellet was then divided into 
100μL aliquots to which 10μL of PCR product was added. This mixture was 
then transferred to an electroporation cuvette and electroporation performed 
using a BIO-RAD MicroPulser at a voltage of 2.5kV. Immediately after 
electroporation, 1mL of sterile LB was added to the cuvette and the mixture 
pipetted into an Eppendorf tube. Electroporated cells were then incubated at 
37°C for an hour to allow recombination. 100μL of cells was then spread on 
agar plates containing the appropriate antibiotic and incubated overnight at 
37°C. Resultant colonies were patched onto a new antibiotic plate the 
following day and subsequently checked by Colony PCR, as described above, 
to determine whether mutagenesis had been successful.  
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2.9.3 P22 mediated transduction  
Successfully mutated DNA was transduced into a clean WT SL1344 
background using the P22 bacteriophage to prevent further recombination 
events from occurring. A single colony of the desired mutant, was used to 
inoculate 10mL of LB with appropriate antibiotic and this culture grown 
overnight. The following day 10μL of this overnight was subcultured into 10mL 
of sterile LB and grown for 1 hour at 37°C. 20μL of SL1344 P22 
bacteriophage was then added and the culture grown for a further 6 hours to 
allow cell infection. Following this, 1mL of CHCl3 was added to the culture and 
gently mixed before being left at 4°C for a minimum of 4 hours. Following 
incubation the solution was centrifuged for 15 minutes at 4°C and the 
resultant supernatant pipetted into a 15mL falcon tube to create a phage stock 
of the mutant. 10μL of this phage stock was then added to 100μL of SL1344 
and incubated for 45 minutes at 37°C before streaking into an appropriate 
antibiotic plate. This plate was then incubated overnight at 37°C and resultant 
single colonies streaked onto a green antibiotic plate and again incubated. 
True-lysogens were identified the following day by their light-green colour and 
re-streaked onto a fresh green plate that was then incubated. True-lysogens 
were again identified and streaked onto an LB plate with appropriate 
antibiotic, following incubation and growth, single colonies were PCR checked 
by Colony PCR to ensure that they contained the desired mutation.  
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2.9.4 Double mutant construction  
Double mutants were created from two single mutant strains with different 
antibiotic cassettes. 10mL LB containing the appropriate antibiotic was 
inoculated with a single colony of one of the two mutant strains. 10μL of this 
was then subsequently subcultured into fresh 10mL LB the following day and 
grown for an hour as described above. 10μL of this culture was then added to 
20μL of phage stock of the second mutant and the protocol continued as 
described in 2.9.3.  
 
Table 5: Primers used for deletion mutagenesis  
Gene Forward Primer Reverse Primer 
STM1586 
TGTGAAGCAGCTATACA
CGTTTTTATCAAAGGGA
GTCGTCGTGTAGGCTG
GAGCTGCTTC 
TAAAGAGATGACTGGAG
GGGTTTCCCCCTCCATA
CCCTATCATATGAATAT
CCTCCTTAG 
STM1250 
ATAAGCCAGTTTTTTGT
TTCAGCGGTGACTGAAA
CATATTGTGTAGGCTGG
AGCTGCTTC 
TAGTCACGAATTTAAGT
GGTTAACGAAAGTCTCA
TCCCGTCATATGAATAT
CCTCCTTAG 
STM2804 
TAGTGCTACAGTGCTCG
TCATCAACACGAGGAGA
AACATG 
GTGTAGGCTGGAGCTG
CTTC 
ACAGAGTTGGCTGACAT
CAGCGCCATCCGGCAA
CAATGCGCATATGAATA
TCCTCCTTAG 
STM4552 
TATGATATTGGTTATCAT
TATCAATTCCAGAGGTG
AAACCGTGTAGGCTGG
AGCTGCTTC 
CTCGCACCAATTATCTT
ATCCTTCCTTTGTCTCTT
CATTTCATATGAATATC
CTCCTTAG 
IbpA-IbpB 
ATGATGGAAGGTCTGAC
ATTCTCGCTGATTTCAG
GAGTTTGTGTAGGCTG
GAGCTGCTTC 
AAAGCCCCGCCATCTCT
GGCGGGGCAAGGCAAG
GAGCTCACATATGAATA
TCCTCCTTAG 
	 77	
STM1250-STM1251 
ATAAGCCAGTTTTTTGT
TTCAGCGGTGACTGAAA
CATATTGTGTAGGCTGG
AGCTGCTTC 
GACAATGAAGGCCCGT
CTAAACGGGCCTCCATT
AACGCGACATATGAATA
TCCTCCTTAG 
ycfR 
AATGCTTACGACACCCA
TTCATCTGCTAAAGGTC
ATCACTGTGTAGGCTGG
AGCTGCTTC 
TTATTGTGGCAATCGCA
GCGGCATTAATGAGGG
TTAATGCCATATGAATA
TCCTCCTTAG 
ybiJ 
ACATCGTCCCATAAACA
GAATAACCTGCGAGAG
ATTAATCGTGTAGGCTG
GAGCTGCTTC 
AACAGCGATGTTACAGC
CTGAAATCTGGCGGGC
AGGTAAA 
CATATGAATATCCTCCT
TAG 
STM3362 
TATCCATGAGTCCAGGT
TCACTTTTGCAGGATAT
ATCCTC 
GTGTAGGCTGGAGCTG
CTTC 
TACGCTATCCGGCTTAC
AAGGCATCTGTAGGCT
GGATAAA 
CATATGAATATCCTCCT
TAG 
NapF GAATTCTCTTCATTTGATTGT 
CTGCAGGATATCGCCCT
TCC 
 
2.9.5 ‘Flipping out’ of the antibiotic resistance cassette 
To combine two or more deletion strains containing the same antibiotic 
resistant cassette it was necessary to first ‘flip out’ the cassette. 
Electrocompetent cells of one strain of interest were created as described in 
2.9.2. 5μL of pCP20 was then added to 100μL aliquot of electro-competent 
cells and electroporated as previously described. Cells were then incubated 
statically at 30°C for three hours to recover and for expression of the 
temperature sensitive Pcp20 plasmid. This plasmid encodes the Flp 
recombinase enzyme of Saccharomyces cerevisiae which recognises the Flp 
recombinase targets (FRT) flanking the antibiotic resistance cassette. 
Production of the FLP recombinase enzyme results in excision of the 
antibiotic cassette (Ellermeier et al, 2002). Following incubation, 100μL of 
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cells were spread onto LB plates containing Ampicillin (Amp) and incubated 
overnight at 30°C. The next day colonies were grown statically in 10mL of LB 
at 45°C to eliminate the Pcp20 plasmid, then diluted 1/5 and 10 or 100μL of 
this dilution spread on LB plates which were incubated at 37°C overnight.  
Following this, colonies were patched onto LB, Amp and Cat or Km pates in 
immediate sucession and again incubated at 37°C overnight. Colonies which 
only gew on LB were patched onto a new LB plate and grown overnight at 
37°C prior to PCR check with verification and internal cassette primers for 
absence of the cassette.    
 
2.10 Sensitivity Assays  
2.10.1 H2O2 Sensitivity Assay 
A 96 well microplate was set up as follows. 100μL of LB media was added to 
the entire top row as a reference. 30% H2O2 was diluted in LB to the desired 
concentration and 100μL of this solution then added to each well in the first 
column of the plate. 50μL of LB was added to all remaining wells and a two-
fold serial dilution performed by taking 50μL of the H2O2 solution from the first 
column and pipetting along the row, mixing thoroughly in between. 50μL of 
overnight culture normalized to an OD600 of 0.02 was then added to each well 
exempting the reference. The microplate was placed in a plate reader and 
shaken before an initial OD600 reading was taken. Following the initial reading 
the plate was incubated statically at 37°C and a reading taken each hour.  
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2.10.2 DetaNONOate Sensitivity Assay  
Assays were performed as described above, using DetaNonoate in place of 
H2O2. An initial concentration of 50mM DetaNonoate was used and a two-fold 
serial dilution again performed. Assays were carried out aerobically and also 
anaerobically by adding 100μL aliquots of mineral oil to each of the wells.  
 
2.10.3 Oxidative Stress Susceptibility Assay  
Assay technique was adapted from the Oxidative stress susceptibility assays 
in Testerman et al, 2002. S. Typhimurium strains were grown overnight at 
37°C and 200 rpm shaking before being diluted to a density of 5 x 105 cfu ml-1 
in sterile PBS. Diluted strains were then challenged with either 0mM or 4mM 
H2O2 and left to stand at room temperature. 100μL aliquots were removed at 
30-minute intervals for the first three hours and then every hour for 7 hours 
and then again at 24 hours. Aliquots were diluted in 10mL PBS before being 
plated as 10μL spots on LB agar plates. Plates were then grown at 37°C 
overnight before counting to quantify colony forming units (cfu).  
 
2.10.4 Nitrosative Stress Susceptibility Assay  
S. Typhimurium strains were grown as previously described in 2.10.3 and 
again diluted to a density of 5 x 105 cfu mL-1 in sterile PBS. Diluted strains 
were then challenged with either 0mM or 7mM detaNONOate and incubated 
statically at 37°C. The assay was then performed as previously described 
excepting that samples were taken every hour for the first 7 hours, then at 30-
minute intervals for 3 hours and then again at 24 hours. 
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2.11 β-galactosidase Assay  
2.11.1 LB and LBS Media  
β-Galactosidase Assays were carried out using strains of S. Typhimurium 
transformed with the pMP220 reporter plasmid encoding the nap-lacZ fusion. 
Universals containing 10mL of either LB or LBS media were inoculated with a 
single colony, and 10μL of tetracycline. Cultures were then grown micro-
oxically and statically at 37°C overnight. 2mL aliquots of the cultures were 
added to micro-centrifuge tubes, centrifuged at 6000rpm for 10 minutes and 
pellets resuspended in 2mL chilled Z-buffer. 1mL of the diluted cells were then 
added to cuvettes and the OD read at 600nm. 100μL chloroform and 50μL of 
0.1% sodium dodecyl sulphate (SDS) was added to the remaining 1mL of 
diluted culture and this mixture vortexed before heated to an equilibrium at 
28°C for 5 minutes. Samples were then removed from the heat block and the 
β-galactosidase activity reaction started by the addition of 0.2mL ONPG 
solution. The samples were then vortexed and placed back in the heat block. 
Once a yellow colour similar to that of LB had developed the reaction was 
stopped by the addition of 0.5mL 1M Na2CO3. This solution raises the pH to 
11 and therefore abrogates the enzymatic reaction. The time taken for the 
yellow colour change from the addition of the ONPG to the termination of the 
reaction with Na2CO3 was recorded.  The 1mL of reaction mixture was then 
centrifuged for 5 minutes at 13000rpm to remove the chloroform and SDS 
before the OD was recorded at 550nm and 420nm. The reaction time, 
reaction volume and OD600, OD420 and OD550 readings were then used to 
calculate the enzyme activity in Miller Units using the following formula:  
1000 x (OD420 – (1.75 x OD550)) / (time (minutes) x volume (mls) x OD600) 
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2.11.2 M9 Minimal Media 
β-galactosidase assays were performed in M9 minimal media containing 
either 10mL 1M Glycerol and 2.5mL 1M Nitrate or vice versa. 50mL of M9 
minimal media was added to 50mL falcon tubes and inoculated with a single 
colony and 50μL of tetracycline. The culture was then sealed with parafilm 
and left to grow anaerobically and statically at 37°C for 20 hours. The entire 
50mL culture was then spun down at 4000rpm for 20 minutes and the pellet 
resuspended in 2mL Z buffer. 1mL of this was added to a cuvette and the 
OD600 recorded. 100μL of the diluted cells was further diluted in 900μL of Z-
buffer in a microcentrifuge tube before the addition of 100μl chloroform and 
50μl SDS. The β-galactosidase assay was then carried out as described 
above.  
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CHAPTER 3:  Construction of mutants and analysis of mutant sensitivity 
to oxidative and nitrosative stress 
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3.1 Introduction 
It is apparent that the nitrosative stress response of Salmonella is critical to 
the bacterium’s survival and pathogenicity within host organisms. Therefore, 
the mechanisms Salmonella employs to eliminate exogenous NO are a 
significant yet largely unknown area of study. Whilst the three 
metalloenzymes NrfA, NorV and HmpA remain the principle and most well 
characterised systems of NO detoxification in Salmonella, additional proteins 
are thought to play important functional roles in nitrosative stress resistance. 
NsrR-regulated genes are likely candidates due to their response to very low 
concentrations of NO (Karlinsey et al, 2012). As previously described, the 
NsrR transcriptional repressor contains a helix-turn-helix DNA binding 
domain, the binding of which is inhibited when the Fe-S clusters within NsrR 
are nitrosylated. Abrogation of NsrR binding occurs at very low NO 
concentrations, resulting in the transcription of genes such as hmpA 
(Gilberthorpe et al, 2007). Fairly recently two genes, STM1808 and ygbA, 
both of which are encoded within the NsrR regulon, have been identified as 
necessary for nitrosative stress resistance in S. Typhimurium. Insertion 
mutations were created in STM1808 and ygbA and the resulting mutant 
strains showed impaired growth in the presence of NO (Karlinsey et al, 2012). 
Such results suggest the involvement of other, yet unidentified, genes in NO 
detoxification besides hmpA.  
ROS produced by macrophages are also capable of inhibiting or killing 
pathogens and Salmonella has means by which it disrupts iNOS activities, 
detoxifies ROS and repairs ROS damage (Burton et al, 2014). While the 
importance of directly bactericidal ROS in Salmonella killing remains vague, 
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oxidative stress is known to be important in the control of Salmonella infection 
(Vazquez-Torres et al., 2000).  For instance, Hydrogen peroxide (H2O2) is 
able to move across bacterial membranes and cause oxidative damage to 
bacterial components (Hébrard et al, 2009). While various oxidative stress 
defence mechanisms have been described in Salmonella, it remains a 
complex area in which much is still unknown.  
The genes investigated within this study are proposed to be involved in some 
capacity in the nitrosative or general stress response of Salmonella. They 
were initially identified in a microarray previously performed by Rowley’s 
group, which revealed that ybiJ, ycfR, STM1250, STM4552, ibpA and 
STM1586 were induced in S. Typhimurium under anaerobic conditions upon 
the addition 40μM aqueous NO (Figure 12). This induction of expression 
implies some contribution to nitrosative stress resistance, or the general 
stress response of S. Typhimurium.  It is possible that some of the genes 
identified in the nitrosative stress assay might also function as oxidative stress 
resistant genes.  
This project therefore aimed to characterise deletion mutants of the 
aforementioned genes and others previously implicated in NO detoxification 
and sought to examine their sensitivity to oxidative and nitrosative stress.  
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STM1586, STM3362 and STM4452. 
Little is known about the majority of genes identified in the before mentioned 
microarray; for instance, STM1586 and STM3362, which are putative 
periplasmic proteins, and STM4452, which is a putative inner membrane 
protein. None of these three genes are thought to be part of the NsrR regulon 
however both STM1586 and STM4452 were upregulated in response to 
nitrosative stress. Whilst STM3362 was not shown to be induced in the 
microarray, it contains a domain of unknown function, DUF1471, which bore 
Figure 12: Salmonella genes up-regulated under nitrosative stress. 
Preliminary data from a microarray showed that upon the addition of 40µM 
aqueous NO, the S. Typhimurium genes STM1250, STM4552, STM1586, 
STM2804, ycfR, ybiJ and ibpA were up-regulated. 	
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further investigation. The relevance of this DUF is described later within this 
chapter. Moreover, STM3362, known as ychH in E. coli, has been shown to 
be upregulated under chlorine oxidation in S. Typhimurium (Wang et al, 
2010). A study in metabolically engineered E. coli also concluded that YchH 
(STM3362) was a stress protein, as it displayed significant sensitivity to H2O2, 
cadmium and acid, as well as involvement in biofilm formation (Lee et al, 
2010). 
 
YcfR 
More is known about the outer-membrane protein YcfR. Studies in E. coli 
showed that ycfR expression was induced under several stress conditions, 
including oxidative stress. Further investigation showed that deletions of ycfR 
in E. coli resulted in strains with increased sensitivity to oxidative stress, as 
well as acid and heat, leading to the conclusion that ycfR is a multiple stress 
resistance protein (Zang et al, 2007).  Wang et al (2009) further showed that 
ycfR was up-regulated in E. coli under oxidative stress from chlorine and 
H2O2.  Studies conducted in S. Typhimurium showed that ycfR was induced 
by chlorine stress and that its deletion resulted in significantly reduced 
chlorine resistance (Salazar et al, 2013). As YcfR functions as a multiple 
stress resistance protein in E. coli, it may indeed perform a similar role in 
Salmonella (Deng et al, 2011). Evidence also suggests this protein may also 
be involved in biofilm formation, where it shows signification upregulation in 
biofilms (Deng et al, 2011; Zang et al, 2007).  
 
 
	 88	
 
YbiJ 
YbiJ, a putative periplasmic protein, was also shown to influence E. coli 
biofilms and a deletion of ybiJ significantly reduced biofilm formation by E. coli 
(Hancock et al, 2010).  Beyond this, little is known about its role in Salmonella 
or E. coli stress responses. It is notable however that YcfR, YbiJ and 
STM3362 all possess the same domain of uncharacterized function, 
DUF1471. Proteins containing this domain have been shown to play roles in 
bacterial stress response, biofilm formation and pathogenesis (Eletsky et al, 
2014). Several members of this family, including ycfR, are up-regulated in 
Salmonella subsequent to the application of oxidative and other stresses 
(Eletsky et al, 2014). It has been proposed that DUF1471 proteins may have a 
direct or indirect influence on the characteristics of the cell surface; though 
more about their role and function in relation to stress remain unclear (Eletsky 
et al, 2014).   
 
IbpA, IbpB, STM1250 and STM1251 
Significantly more research has been performed on ibpA and the closely 
related ibpB, two small heat shock chaperones which bind to denatured 
proteins, preventing further protein aggregation and leading to their 
reformation (Matuszewska et al, 2008). Unsurprisingly both ibpA and ibpB are 
up-regulated in Salmonella and E. coli in response to heat stress. These two 
proteins have a multiprotein structure which dissociates at high temperatures 
and aid in the refolding or degradation of damaged proteins (Lethanh et al, 
2005). 
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 Strains of E. coli which overexpressed ibpA and ibpB were found to be more 
resistant to both heat and superoxide stress, though not to hydrogen 
peroxide. However, further testing with ibpAB-disrupted strains showed them 
to be no more sensitive to these stresses than WT controls (Kitagawa et al, 
2000). Salmonella, unlike E. coli, also produces two ibpA and ibpB 
homologues, STM1250 and STM1251 respectively. IbpA shares 35% 
sequence identity with STM1250 and IbpB shares a 31% sequence identity 
with STM1251. In order to observe a mutant phenotype all four genes must 
therefore be removed to ensure that these homologues do not compensate 
for each other and mask the effect of the deletion.  
 
3.2 Aims  
The first aim of this study was the construction of deletion strains for all genes 
of interest (GOI) detailed above. Once strains had been confirmed to have the 
desired mutations it was then necessary to ensure that they displayed no 
significant general fitness defects compared to the WT strain that would 
impact future results. The final aim of this chapter was to determine whether 
mutants demonstrated increased sensitivity to nitrosative and / or oxidative 
stress in comparison to the WT strain, therefore indicating involvement of the 
GOI in the response of Salmonella to these stressors.  
 
3.3 Methods 
3.3.1 Construction of gene deletions  
Single deletion mutants of all the GOI were constructed as well as double 
mutant strains of ibpA-ibpB and STM1250-STM1251 respectively. To try and 
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unpick functional redundancy, a quadruple mutant was then constructed of 
ibpA, ibpB, STM1250 and STM1251, as well as a triple mutant of STM3362, 
ybiJ, ycfR to examine the involvement of DUF471-containing proteins to 
stress responses in S. Typhimurium. Mutants were constructed using λ Red 
Recombination, a technique that utilizes the bacteriophage λ homologous 
recombination proteins to recombine linear DNA containing short homologies 
with appropriate target sequences. It is highly efficient in that it requires only 
50 bases of homology for efficient recombination and can be used to make 
precise insertions, point mutations and deletions in Salmonella (Mosberg et al, 
2010). The Salmonella strain used in this study is Salmonella enterica 
enterica serovar Typhimurium str. SL1344 and all subsequent mutants 
derived from this original WT strain. Targeted genes were excised and 
replaced with antibiotic resistance cassettes encoding resistance for either 
chloramphenicol (pKD3) or kanamycin (pKD4) and flanked with a flippase 
recognition target (FRT) to allow for later removal.  These cassettes were first 
PCR amplified from the plasmids pKD3 and pKD4 using primers designed for 
the deletion of targeted genes. These primers may be found in Table 5.  This 
resulted in a linear PCR product consisting of the antibiotic cassette and 40bp 
overhanging ends homologous to the start and end of the gene to be removed 
(Figure 11). This PCR product was then purified and electroporated into a S. 
Typhimurium SL1344 strain containing the pkD46 plasmid, which encodes the 
arabinose inducible recombinase enzymes of phage λ (γ, β, exo).  
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Figure 13: Creation of linear PCR product. Gel electrophoresis of 
mutagenesis primers and either pKD3 or pKD4 DNA. 
Lane 1: pDK3 STM4552 Lane 2: pKD4 STM4552 Lane 3: pKD3 STM1250, 
Lane 4: pDK4 STM1250 Lane 5: pKD3 STM2804 Lane 6: pKD4 STM2804 
Lane: 7: pDK3 STM1586 Lane: 8 pKD4 STM1586. 
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3.3.2 Confirmation of single gene knockouts  
Mutants were confirmed by colony PCR using verification primers external to 
the loci where the mutation should have occured and internal primers which 
amplified the pKD3 or pkD4 casette (Figure 13). Once mutagenesis was 
confirmed, successful recombinants were transduced into a clean S. 
Typhimurium SL1344 background to prevent further recombination from 
occuring. These recombinants were then plated on green plates containing 
the dyes alizarin yellow G and aniline blue. Lysogenic colonies appear dark 
green on such plates, whilst true lysogens appear light green, allowing for 
their differentiation and selection. Mutant confirmation with external and 
internal primers was again performed following true-lysosgen selection 
(Figure 14). Mutant strains of ycfR, ybiJ and STM3362 previously created 
were also re-confirmed by colony PCR (Figure 15).  
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Figure 14 (A-D): Confirmation of novel single mutant strains. (A) PCR Check with 
external verification primers for mutant STM4552 and STM1250. Lane 1: WT STM4552, 
Lane 2: ∆STM4552::cat, Lane 3: ∆STM4552::kan, Lane 4: WT STM1250, Lane 5: 
∆STM1250::cat, Lane 6: ∆STM1250::kan. (B) PCR check with internal verification primers 
for mutant STM4552 and STM1250. Lane 1: WT STM4552, Lane 2: ∆STM4552::cat, Lane 
3: WT STM4552, Lane 4: ∆STM4552::kan, Lane 5: WT STM1250, Lane 6: 
∆STM1250::cat, Lane 7: WT STM1250, Lane 8: ∆STM1250::kan. (C) PCR check with 
external verification primers for mutant STM1586 from numerous colonies. Lane 1: WT 
STM1586, Lane 2-9:  ∆STM1586::kan (D) PCR check with internal primers for mutant 
STM1586 from numerous colonies. Lane 1: WT STM1586, Lane 2-9: ∆STM1586::kan. 
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Figure 14 (E): Confirmation of novel single deletion strains (E) PCR 
confirming all single mutants with external verification primers. Lane 1: 
WT STM1250, Lane 2: ∆STM1250::cat, Lane 3: ∆STM1250::kan, Lane 4: 
WT STM4552, Lane 5: ∆STM4552::cat, Lane 6: ∆STM4552::kan, Lane 7: 
WT STM1586, Lane 8: STM1586::kan. 
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Figure 15: Confirmation of existing ΔybiJ, ΔycfR and ΔSTM3362. (A) 
PCR confirmation with external primers for the mutants of ybiJ, ycfR and 
STM3362. Lane 1: WT ybiJ, Lane 2: ∆ybiJ::kan, Lane 3: WT ycfR, Lane 4: 
∆ycfR::kan, Lane 5: WT STM3362, Lane 6: ∆STM3362::kan (B) PCR 
confirmation with internal primers for the mutants of ybiJ, ycfR and 
STM3362. Lane 1: WT ybiJ, Lane 2: ∆ybiJ::kan, Lane 3: WT ycfR, Lane 4: 
∆ycfR::kan, Lane 5: WT STM3362, Lane 6: ∆STM3362::kan. 
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3.3.3 Creation and confirmation of double, quadruple and triple mutants 
Due to the adjacent location of the ibpA and ibpB and the STM1250 and 
STM1251 genes they could each be replaced simultaneously by one antibiotic 
resistance casette. The resultant recombinant was therefore a double mutant, 
either for ΔibpA-ibpB or ΔSTM1250-STM1251, elsewise construction was 
identical to single mutant creation.   
 
From these double mutants it was possible to create a ΔibpA-ibpB-STM1250-
STM1251 quadruple mutant. It was necessary to use mutants containing two 
different antibtiotic casettes and therefore STM1250-STM1251 with resistance 
to chloramphenicol and ibpA-ibpB with resistance to kanamycin were used 
(Figure 16, Figure 17). The phage transduction step was carried out once 
more, using one double mutant as the donor strain and the other in place of 
the clean SL1344 background. The successful quadruple mutant was then 
confirmed by PCR using both external and internal verification primers (Figure 
18).  
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Figure 16: Confirmation of ∆STM1250-STM1251::cat double mutant. (A) PCR 
check with external verification primers of numerous colonies for ∆STM1250-
STM1251::cat. Lane 1: WT STM1250-STM1251, Lane 2-9: ∆STM1250-
STM1251::cat. (B) PCR check wit internal verification primers of numerous colonies 
for ∆STM1250-STM1251::cat. Lane 1: WT STM1250-STM1251, Lane 2-9: 
∆STM1250-STM1251::cat 
1   2   3   4    5    6    7    8   9         1   2   3    4   5   6    7    8     9            
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Figure 17: Confirmation of ∆IbpA-IbpB::kan and ∆STM1250-STM1251::kan (A) 
PCR check with external verification primers for IbpA-IbpB and STM1250-
STM1251. Lane 1: WT IbpA-IbpB, Lane 2: WT IbpA-IbpB, Lane 3-6: ∆IbpA-
IbpB::kan, Lane 7: WT STM1250-STM1251, Lane 8-11: ∆STM1250-STM1251::kan 
(B) PCR check with internal verification primers for IbpA-IbpB and STM1250-
STM1251. Lane 1: WT IbpA-IbpB, Lane 2-5: ∆IbpA-IbpB::kan Lane 6: WT 
STM1250-STM1251, Lane 7-10: ∆STM1250-STM1251::kan. 	
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Figure 18: Confirmation of ∆IbpA-IbpB - STM1250-STM1251 quadruple 
mutant with both internal and external verification primers. Lane 1: WT 
IbpA-IbpB (external), Lane 2: ∆IbpA-IbpB::kan (external), Lane 3: WT IbpA-IbpB 
(internal), Lane 4: ∆IbpA-IbpB::kan (internal), Lane 5: WT STM1250-STM1251 
(external), Lane 6: ∆STM1250-STM1251::cat (external), Lane 7: WT STM1250-
STM1251 (internal), Lane 8: ∆STM1250-STM1251::kan  
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The STM3362-ycfR-ybiJ triple mutant construction required a further step in 
the process, where the antibiotic casette in ΔSTM3362 was first ‘flipped out’ 
(Figure 19). This was accomplished by electroporating the plasmid pcP20 into 
competent cells of ΔSTM3662. This plasmid encodes the temperature 
sensitive yeast Flp recombinase gene, flp, and resistance to ampicillin. 
Following induction at the correct temperature the flp protein recognizes the 
FRT sequences flanking the antibiotic casette and flips this casette out. The 
resulting clean mutant of ΔSTM3362 was phage transduced with lysate raised 
on ΔycfR::cat (Figure 20), creating a ΔSTM3362-ycfR double mutant which 
was confirmed by colony PCR (data not shown). This double mutant was then 
tranduced with ΔybiJ::kan to create STM3362-ycfR-ybiJ. The successful triple 
mutant was confirmed with both internal and external primers (Figure 21).  
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Figure 19: PCR check confirming ∆ycfR::cat (A) PCR check with 
external primers for ∆ycfR::cat, Lane 1: WT, Lane 2 – 9: ∆ycfR::cat (B) 
PCR check with internal primers for ∆ycfR::cat, Lane 1: WT ycfR, Lane 2-9: 
∆ycfR::cat 
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Figure 20: PCR check with internal and external verification 
primers for flipped out ∆STM3362::kan Lane 1: WT STM3362 
(external), Lane 2: ∆STM3362::kan (external), Lane 3-5: flipped 
STM3362 (external), Lane 6: WT STM3362 (internal), Lane 7: 
∆STM3362::kan (internal), Lane 8-10: flipped STM3362 (internal). 
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Figure 21: PCR check with internal and external verification primers for 
∆STM3362-ycfR-ybiJ triple mutant. Lane 1: WT STM3362 (external), Lane 2: 
STM3362 flipped (external), Lane 3: STM3362 flipped (external), Lane 4: WT 
STM3362 (internal), Lane 5: STM3362 flipped (internal), Lane 6: STM3362 flipped 
(internal), Lane 7: WT ycfR (external), Lane 8: ∆ycfR::cat (external), Lane 9: 
∆ycfR::cat (external), Lane 10: WT ycfR (internal), Lane 11: ∆ycfR::cat (internal), 
Lane 12: ∆ycfR::cat (internal), Lane 13: WT ybiJ (external), Lane 14: ∆ybiJ::kan 
(external), Lane 15: ∆ybiJ::kan (external), Lane: 16 WT ybiJ (internal), Lane 17: 
∆ybiJ::cat (internal), Lane 18: ∆ybiJ::cat (internal). 
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3.3.4 Aerobic Growth Curves in nutrient sufficient LB media 
Growth curves were carried out in nutrient sufficient LB media under aerobic 
conditons for all mutant strains alongside the SL1344 Salmonella WT, 
facillitating growth comparison. Strains were normalised to an OD of 0.02 at 
600nm in 50mL of LB broth and grown for 8 hours at 37°C, 200 rpm with 
OD600 measured at 1-hour intervals to determine bacterial growth.  
 
3.3.5 Nitrosative and Oxidative Stress Sensitivity Assays  
The effect of oxidative and nitrosative stress on deletion mutants in 
comparison with the S. Typhimurium WT strain SL1344 was determined 
through various sensitivity assays. Hydrogen peroxide was used as a source 
of oxidative stress whilst nitrosative stress was induced by use of Deta-
NONOate. NONOates are compounds containing three sequential nitrogen 
atoms, enabling them to release NO when in solution. The majority of 
NONOates are stable in alkaline solution above pH 8.0 and generate NO 
when the pH is lowered. Per 1M of parent compound, Deta-NONOate 
releases 2M of NO and has a half-life of 20 hours at 37°C or 56 hours at room 
temperature when at pH 7.4.  
 
3.3.5.1 Hydrogen Peroxide Sensitivity Assays  
H2O2  sensitivity assays were performed using serial dilutions of 30% H2O2 in 
96 well plates. Cultures of mutant strains ∆STM1250, ∆STM1250-STM1251, 
∆ibpA-ibpB and ∆ibpA-ibpB-STM1250-STM1251 and the WT strains were 
normalized to a starting density of 0.02 OD600 before addition to the serial 
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dilution. The microplate was incubated statically at 37°C and the OD600 of 
cultures taken via plate reader each hour.  
  
3.3.5.2 DetaNonoate Sensitivity Assays 
DetaNONOate sensitivity assays were performed much the same way as 
described above, excepting that DetaNONOate was utilised as a source of 
stress. An initial concentration of 50mM DetaNonoate was used and a two-
fold serial dilution again performed. The assay was carried out under both 
aerobic and anaerobic conditions; the later of which was accomplished by the 
addition of 100μL of mineral oil to each of the wells.  
 
3.3.5.3 Oxidative Stress Susceptibility Assays 
Oxidative stress susceptibility assays were adapted from Testerman et al, 
2002. Mutant and WT strains were challenged with either 0mM or 4mM H2O2 
and left to stand at room temperature. Aliquotes were removed at 30 minute 
intervals for the first three hours and diluted before being plated as 10μL 
spots on LB agar plates. This then continued at 1 hour-intervals for 24 hours. 
Susceptibility of strains to oxidative stress was determined by cfu on LB agar 
plates after incubation at 37°C overnight.  
 
3.3.5.4 Nitrosative Stress Susceptibility Assays  
Stress susceptibility assays were again adapted from Testerman et al, 2002. 
The assay was performed as previously described for oxidative stress 
excepting that nitrosative stress was investigated instead by use of the NO 
donator detaNONOate. Strains were exposed to either 0mM or 7.5mM 
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detaNONOate. Aliquots were taken every hour for the first 7 hours, then at 30-
minute intervals for 3 hours and then again at 24 hours. 
 
3.4 Results 
3.4.1 Mutant growth is comparable to WT in LB nutrient rich media  
Wild-type and mutant strains were grown in nutrient rich LB media to ensure 
there were no major issues with general fitness of the strains. All mutants 
showed very similar growth to wild-type under these conditons (Figures 22, 
23, 24).  
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Figure: 22 Growth of WT and single mutants in LB media. Growth of 
WT, ∆STM1250, ∆STM4552, ∆STM1586, ∆STM3362, ∆ycfR and ∆ybiJ 
and ∆STM3362 under aerobic conditions in 50ml LB media. Cultures 
were grown for 24 hours at 37°C, aliquots were removed and the OD600 
read every hour. 
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Figure 23: Growth of WT and multiple mutants in LB media. Growth 
of WT, ∆STM1250, ∆STM1250-STM1251, ∆IbpA-IbpB, and ∆STM1808-
tehB-yeaR-HmpA were under aerobic conditions in 50ml LB media. 
Cultures were grown for 24 hours at 37°C, aliquots were removed and 
the OD600 read every hour. 
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Figure 24: Growth of WT, triple and quadruple mutants in LB media. 
Growth of WT, ∆IbpA-IbpB-STM1250-STM1251 and ∆STM3362-ycfR-
ybiJ-were under aerobic conditions in 50ml LB media. Cultures were 
grown for 24 hours at 37°C, aliquots were removed and the OD600 read 
every hour. 
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3.4.2 Single Mutants are no more sensitive to nitrosative stress than WT 
S. Typhimurium 
Single mutants and the WT strain were exposed to 12.5mM DetaNonoate as 
a source of nitric oxide under both aerobic and anerobic conditons. The 
quadruple mutant ΔSTM1808-yeaR-tehB-hmpA which has previously been 
shown by the Rowley lab to display extreme sensitivity to nitrosative stress 
was used to demonstrate the functionality of the assay. Single mutants did not 
appear to be more sensitive to nitrosative stress than the WT strain under 
either aerobic or anaerobic conditons (Figure 25, Figure 26).  
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Figure 25: Sensitivity of WT and single mutants to NO under aerobic 
conditions. The WT strain and mutant strains ∆STM1250, ∆STM4552, 
∆STM1586, ∆ycfR and ∆STM3362 were grown aerobically in 96 well plates at 
37°C with LB and 12.5mM DetaNONOate. OD readings were taken every hour 
using a plate reader at 600nm. 
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Figure 26: Sensitivity of WT and single mutants to NO under anaerobic 
conditions. The WT strain and mutant strains ∆STM1250, ∆STM4552, 
∆STM1586, ∆ycfR and ∆STM3362 were grown anaerobically in 96 well plates at 
37°C with LB and 12.5mM DetaNONOate. OD readings were taken every hour 
using a plate reader at 600nm. 
	 111	
3.4.3 ∆STM1250-STM1251, ∆ibpA-ibpB and ∆ibpA-ibpB-STM1250-
STM1251 are more sensitive to nitrosative stress than WT S. 
Typhimurium 
Multiple mutants and the WT strain were exposed to 12.5 mM DetaNonoate 
as a source of nitrosative stress under both aerobic and anerobic conditons. 
Again, the quadruple mutant ΔSTM1808-yeaR-tehB-hmpA was used to 
demonstrate the functionality of the assay. Multiple mutants appeared to be 
more sensitive to nitrosative stress than the WT strain under both aerobic, 
and particularly, anaerobic conditons. Interestingly survival and growth were 
most affected in the ΔibpA-ibpB double mutant rather than the quadruple 
ΔibpA-IbpB-STM1250-STM1251 (Figure 27, Figure 28).  
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Figure 27: Sensitivity of WT and multiple mutants to NO under aerobic 
conditions. The WT strain and mutant strains, ∆STM1250-STM1251, ∆ibpA-ibpB and 
∆ibpA-ibpB-STM1250-STM1251 were grown aerobically in 96 well plates at 37°C with 
LB and 12.5mM DetaNONOate. OD readings were taken every hour using a plate 
reader at 600nm. 
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Figure 28: Sensitivity of WT and multiple mutants to NO under anaerobic 
conditions. The WT strain and mutant strains ∆STM1250-STM1251, ∆ibpA-ibpB 
and ∆ibpA-ibpB-STM1250-STM1251 were grown anaerobically in 96 well plates at 
37°C with LB and 12.5mM DetaNONOate. OD readings were taken every hour 
using a plate reader at 600nm. 
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3.4.4 ΔSTM1250-STM1251, ΔibpA-ibpB, ΔibpA-ibpB-STM1250-STM1251 
and  ΔSTM3362-ycfR-ybiJ are more sensitive to oxidative stress than WT 
S. Typhimurium  
Multiple mutants and SL1344 WT strain were exposed to hydrogen peroxide 
as a source of oxidative stress. Mutiple mutants, ∆STM1250-STM1251, 
∆ibpA-ibpB and ∆ibpA-ibpB-STM1250-STM1251 all appeared to be more 
sensitive to oxidative stress than the WT strain, particularly the IbpA-IbpB 
double mutant (Figure 29).  
Hydrogen peroxide susceptibility assays were also performed with the triple 
mutant, ∆STM3362-ycfR-ybiJ, quadruple mutant, ∆ibpA-ibpB-STM1250-
STM1251, and the WT strain at concentrations of 0mM and 4mM H202.  As 
shown in Figure 30, survival of both mutants is impaired in comparison to WT 
S. Typhimurium, with ∆ibpA-ibpB-STM1250-STM1251 being the most 
severely affected. This difference in survival is most apparent in the first 3 
hours, and by 8 hours all strains have been eradicated by oxidative stress. 
These results suggest that ∆ibpA-ibpB-STM1250-STM1251 and ∆STM3362-
ycfR-ybiJ are both more sensitive to oxidative stress than WT S. Typhimurium 
SL1344.  
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Figure 29: Sensitivity of WT and multiple mutants to H2O2. The WT strain 
and mutant strains ∆STM1250-STM1251, ∆ibpA-ibpB and ∆ibpA-ibpB-
STM1250-STM1251 were grown in 96 well plates at 37°C with LB and 3mM 
H202. OD readings were taken every hour using a plate reader at 600nm. 
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Figure 30: Susceptibility of WT and ΔibpA-ibpB-STM1250-STM1251 
and ΔSTM3362-ycfR-ybiJ to H2O2. Strains were grown in either 0mM or 
4mM H202 in M9 minimal media without glucose or nitrate for 8 hours at 
room temperature. Aliquots were removed at regularly timed intervals, 
diluted in PBS and plated on LB agar for quantification of colony-forming 
units. 
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3.4.5 The double mutant ΔibpA-IbpB displays the greatest senstivity to 
NO 
To explore the respective contributions of the homologues IbpA & IbpB, and 
STM1250 & STM1251 to the NO sensitivity of the quadruple mutant a similar 
assay was performed. In this assay DetaNonoate agin was used as a source 
of nitrosative stress, with strains exposed to 0mM and 7.5mM DetaNonoate 
Results shown in Figure 31 indicate that the double mutant ΔibpA-IbpB is the 
strain effected most by nitrosative stress, whilst the double mutant 
ΔSTM1250-STM1251 is slightly less susceptible.  
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Figure 31: Susceptibility of ΔibpA-ibpB-STM1250-STM1251, ΔibpA-
ibpB and ΔSTM1250-STM1251 to DetaNONOate. Strains were grown in 
either 0mM or 7.5mM DetaNONOate in M9 minimal media without glucose 
or nitrate for 20 hours at room temperature. Aliquots were removed at 
regularly timed intervals, diluted in PBS and plated on LB agar for 
quantification of colony-forming units. 
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3.5 Discussion 
Whilst three main NO-consuming systems, Hmp, NorVW and NrfA, have been 
characterised, it is thought that other yet-unelucidated mechanisims may 
contribute to NO stress resistance and detoxification in S. Typhimurium.  This 
has been indicated by studies showing that S. Typhimurium strains are able to 
survive anaerobic nitrosative stress even when functional hmpA, norV and 
nrfA are abrogated (Mills et al, 2008; Torres et al, 2016).  
This chapter aimed to further investigate this possibility on the basis of 
preliminary data from the Rowley laboratory which showed up-regulation of 
various S. Typhimurium genes in response to nitrosative stress. To address 
whether these genes were involved in Salmonella nitrosative or oxidative 
stress response, deletion mutant strains were constructed and exposed to 
either oxidative stress (hydrogen peroxide) or nitrosative stress 
(detaNONOate) at physiologically relevant levels.  
 
Construction of both single and multiple mutants by λ Red Recombination was 
largely successful. The exception to this was a mutant strain of STM2804, 
which was attempted numerous times but failed to yield a confirmed mutant 
following the phage transduction stage. The study therefore moved forward 
with the single mutant strains, ΔSTM4452, ΔSTM1250, ΔSTM1586, 
ΔSTM3362, ΔybiJ, ΔycfR and the multiple mutant strains, ΔibpA-ibpB, 
ΔSTM1250-STM1251, ΔibpA-IbpB-STM1250-STM1251 and ∆STM3362-ycfR-
ybiJ. Of the above listed genes, STM4452, STM1250, STM1586, ycfR, ybiJ 
and ibpA were investigated due to their up-regulation in the microarray. YcfR 
was of particular interest due to its apparent role in chlorine stress resistance 
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in S. Typhimurium and as a multiple stress resistance protein in E. coli (Deng 
et al, 2011; Salazar et al, 2013). Strains including mutations in ibpB and 
STM1251 were also created due to the homologous nature of ibpA and ibpB, 
and STM1250 and STM1251, respectively. This was to ensure that resulting 
phenotypes were not masked by genetic redundancy.  
Studies have indicated a role for STM3362 in resistance to stressors such as 
H2O2, chlorine and cadmium (Eletsky et al, 2014; Lee et al, 2010; Wang et al, 
2010). As such a mutant strain of this gene was created and utilised to further 
construct the triple mutant, ∆STM3362-ycfR-ybiJ. This triple mutant was of 
interest due to the existence of a DUF1471 domain in all three of these 
proteins. The suggested involvement of proteins containing the DUF1471 
domain in stress response invited examination of these genes, both 
individually and collectively, in the Salmonella response to NO and H2O2.  
 
Growth curves in nutrient rich media performed prior to stress sensitivity 
assays demonstrated that single mutant growth was equivalent to the isogenic 
parent strain, SL1344. Identical growth curves performed with the multiple 
mutants confirmed similar results, showing no growth deficiencies in 
comparison to the WT. Results achieved for subsequent assays were 
therefore uninfluenced by any inherent growth defects within mutant strains.  
 
Despite preliminary microarray results showing the up-regulation of STM1250, 
STM4552, STM1586, and ycfR in response to 40mM aqueous NO, sensitivity 
assays performed in this study failed to demonstrate increased sensitivity of 
mutant strains of these genes to nitrosative stress. Similarly, ΔSTM3362, 
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containing a DUF1471 domain, was no more susceptible to NO killing than 
the WT strain. Such results were attained under both anaerobic and aerobic 
conditions, consequently leading to the conclusion that none of these genes 
appeared vital in the nitrosative response of S. Typhimurium in either oxic or 
anoxic environments.  
 
In contrast, multiple mutants displayed increased sensitivity to nitrosative 
stress under both aerobic and anaerobic conditions in comparison to WT S. 
Typhimurium. ΔibpA-ibpB-STM1250-STM1251, ΔibpA-ibpB and ΔSTM1250-
STM1251 all showed decreased growth in the presence of NO.  Similarly, 
when challenged with oxidative stress these multiple mutants again 
demonstrated reduced growth in comparison to SL1344.  
 Unexpectedly, the double mutant ΔibpA-ibpB showed greater sensitvity to 
nitrosative and oxidative stress than the quadruple mutant ΔibpA-ibpB-
STM1250-STM1251. It is perhaps possible that the deletion of all four genes, 
and thus both homologue pairs of similar function, leads to a compensatory 
response in S. Typhimurium by which the bacterium responds to the deletion 
to mitigate its negative impact on survival. This would be an example of 
genetic redundancy, where genes of duplicate function are able to 
compensate should one fail, allowing for greater adaptibility and robustness of 
the organism (Nowak et al, 1997). Such a compensatory mechanism would 
explain why a deletion of ibpA and ibpB resulted in a more stress susceptible 
strain than ΔibpA-ibpB-STM1250-STM1251, as it retained the ibpA and ibpB 
homologues STM1250 and STM1251 which may perform similar, yet less 
efficient, functions in Salmonella stress response. This would make sense in 
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that Salmonella alone posses these homologues, whereas the similar 
microoganism E. coli functions competently with solely ibpA and ibpB. 
Currently it is unclear why STM1250 and STM1251 are present in Salmonella 
alone.  
Whilst results showed that the double mutant ΔibpA-ibpB was more 
susceptible to nitrosative stress under aerobic conditons than either ΔibpA-
ibpB-STM1250-STM1251 or ΔSTM1250-STM1251, under anaerobic 
conditons, ΔibpA-ibpB and ΔSTM1250-STM1251 displayed near identical 
susceptibility to NO. It may therefore be proposed that STM1250 and 
STM1251 serve a more considerable contribution to NO resistance under 
anoxic or low oxygen conditons than they do in aerobic environments, or that 
IbpA and IbpB are less vital in the anaerobic nitrosative stress response than 
under aerobic conditons. However far more experimentation would be 
required before either supposition could be substantiated.  
 
Susceptibility assays described and implemented by Testerman et al, were 
modified to investigate the impact of both oxidative and nitrosative stress on 
mutant strains. This additional testing with susceptibility assays showed that 
both ΔibpA-ibpB-STM1250-STM1251 and the triple mutant, ΔSTM3362-ycfR-
ybiJ were sensitive to oxidative stress. When challenged with 4mM H2O2, both 
mutant strains showed decreased survival than that demonstrated in the 
absence of oxidative stress. Furthermore, both ΔibpA-ibpB-STM1250-
STM1251  and ΔSTM3362-ycfR-ybiJ were more susceptible to oxidative 
killing than the isogenic parent strain at the same concentration of hydrogen 
peroxide, with ΔibpA-ibpB-STM1250-STM1251 being the most affected. 
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ΔSTM3362-ycfR-ybiJ was of interest due to the presence of DUF1471, 
exclusive to Enterobacteriaceae and commonly found in proteins involved in 
extracellular stress responses (Eletsky et al, 2014). The susceptibility of 
ΔSTM3362-ycfR-ybiJ to oxidative stress suggests that these genes may 
indeed play minor roles in the oxidative stress reponse of S. Typhimurium. 
 
NO susceptibity assays were also performed on ΔibpA-ibpB-STM1250-
STM1251, ΔibpA-ibpB and ΔSTM1250-STM251 using physiologically revelant 
levels of nitric oxide provided by 7.5mM of deta NONOoate (Hussain et al, 
2014). Results similarly showed that these mutant strains were sensitive to 
NO killing. Whilst all strains were effected, based on strain survival in the 
absence of NO, ΔibpA-ibpB again appeared to be most susceptible to 
nitrosative stress. Similarly, the second most susceptible was the quadruple 
mutant ΔibpA-ibpB-STM1250-STM1251, whilst ΔSTM1250-STM251 showed 
slightly higher survival. Results of this assay therefore complemented those 
achieved for these multiple mutants in sensitivity experiements.  
 
It is possible to conclude therefore that results from this study suggest a role 
for various S. Typhimiurium genes in oxidative and nitrosative stress survival 
other than hmpA, norVW and nrfA.  
Though single mutants did not display increased NO sensitivity, is is plausible 
that with the main NO detoxficiation protein HmpA still functional and active, 
the deletion phenotype of these genes were not signficant enough to effect 
Salmonella survival. Whilst such results suggest that their influence is 
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minimal, it does not eliminate the possibility of their involvement in NO 
detoxification entirely.  
In contrast, based on results of susceptibility assays ΔSTM3362-ycfR-ybiJ 
may be involved in the oxidative stress tolerence of S. Typhimurium, while 
mutant strains ΔibpA-ibpB, ΔSTM1250-STM1251 and ΔibpA-ibpB-STM1250-
STM1251 all demonstrate increased sensitivity to both NO and H2O, therefore 
suggesting a role for these genes in NO detoxification and the oxidative stress 
response. IbpA and IbpB in particular appear to have a signficant effect on 
strain survival of these stressors which bears further investigation. These two 
small heat shock proteins share a 48% sequence identity  and are known to 
be upregulated in E. coli and Salmonella following heat stress, where they act 
to prevent protein aggregation (Matuszewska et al, 2005; Laskowska et al, 
1996; Carroll et al, 2016).  It has been previously proposed that IbpA and IbpB 
are also involved in some capacity in oxidative stress tolerence in E. coli, with 
bacteria overexpressing ibpA/B showing increased resistance to superoxide 
stress (Kitagawa et al, 2000).  Further in vitro study by the same group 
showed that IbpA and IbpB were capable of supressing the inactivation of 
enzymes by H2O2 and potassium superoxide (Kitagawa et al, 2002). Strains 
of E. coli deficient in ibpA/B also show higher sensitivity to superoxide radicals 
produced by potassium tellurite (Perez et al, 2007). Furthermore, it appears 
that under aerobic conditons IbpA/B protect cells from copper-induced stress, 
with DibpA/B strains showing increased sensitivity to oxidative damage from 
copper ions (Matuszewska et al, 2008). More recently, non-pathogenic E. coli 
inside macrophages were found to upregulate ibpA/B in response to ROS, 
where ibpA/B appeared to then protect E. coli from ROS killing (Goeser et al, 
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2015). Although less is known about ibpA/B expression in response to NOS, 
the results of this study suggest that IbpA and IbpB may play a minor role in 
both oxidative and nitrosative stress tolerence. 
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CHAPTER 4: Regulation of the napF operon by the SPI-1 transcriptional 
activator HilA 
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4.1 Introduction 
As previously discussed, the Salmonella HilA transcriptional regulator is the 
well-characterised activator of SPI-1 (Baxter & Jones, 2015). The genes of 
SPI-1 are expressed when Salmonella reaches the intestinal lumen and 
associate with the epithelial cells or enterocytes where they are required for 
invasion of the intestinal epithelium (Fàbrega & Vila et al, 2013). SPI-1 
encodes a TTSS and effector proteins which lead to distortion of the host cell 
membrane and ultimately the entry of the bacterium (Martinez et al, 2014). As 
the master regulator of SPI-1 the upregulation of HilA is necessary for the 
expression of SPI-1 genes and subsequent host-cell invasion (Bajaj et al, 
1995; Baxter & Jones, 2015). Mechanistically, HilA binds directly to and 
activates the SPI-1 TTSS promoter and also induces InvF, an AraC-like 
transcriptional regulator that induces expression of SPI-1 secreted effectors 
(Lucas & Lee, 2001). HilA itself is a member of the ToxR/OmpR-like family of 
transcriptional regulators and its expression is induced by several 
transcriptional factors which include HilC, HilD, RtsA, PhoP, SirA and Fis (De 
Keersmaecker et al, 2005).  Environmental cues thought to induce the 
expression of HilA, and therefore SPI-1, are those found in the host intestinal 
lumen, including high osmolarity, low pH and anoxic conditons. (Lunderberg 
et al, 1999).  
Data obtained from previously performed herarchial cluster analysis by Alston 
et al (unpublished data) showed that  expression of SPI genes correlated with 
5 nap genes, napFDHBC (Figure 32A). Furthermore a S. Typhimurium nap 
deletion mutant showed decreased invasive ability when compared with 
SL1344 WT (Alston et al, unpublished data; Prior, 2011).  Nap is the 
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periplasmic nitrate reductase of Salmonella which is encoded by the NapF 
operon. Under nitrate-limited conditons it is thought to be the main nitrate 
reductase in nitrate metabolism, allowing Salmonella to survive under 
anaerobic conditons. Due to its higher-affinity for nitrate it is able to function in 
concentrations of nitrate too low to support respiration by the membrane-
bound nitrate reductase, NarG (Rowley et al, 2012). The expression of SPI-1 
genes clustered with nap expression may indicate that they share a common 
transcriptional regulator,  HilA. Furthermore, the upstream sequence of napF 
was aligned with other known HilA targets, including invF, and a potential HilA 
box was identified (Figure 32B). Moreover, as the nap deletion mutant shows 
an impaired ability to invade epithelial cells, it is possible that these nap genes 
could play a role in Salmonella invasion in concert with SPI-1. It is therefore 
plausible and worth investigation whether SPI-1 and nap share a common 
transcriptional activator in HilA.  
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Figure 32: Expression of Nap genes coincides with SPI-1 gene 
expression. (A) Hierarchical cluster analysis by Alston’s group suggests that 
SPI1 genes cluster with 5 nap genes, napFDHBC. It is a possibility therefore 
that SPI-1 and Nap may have a co-regulatory mechanism, HilA, and that Nap 
genes may play a role in invasion. (B) Upon sequence analysis of the napF 
operon a potential sequence was identified which might serve as a HilA box, 
such as found in other HilA targets. 
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4.2 Aims 
The aim of this chapter was to determine whether HilA, the transcriptional 
activator of SPI-1 also acts as an activator of the Nap nitrate reductase. 
Salmonella strains containing a nap-lacZ fusion were first grown on 
tetracycline selective antibiotic resistance plates to confirm they contained the 
pMP220 plasmid. Following this, β-galactosidase assays were performed in 
both SPI-1 inducing conditions and plain LB to acess whether SPI-1 induction, 
and therefore hilA activation, corresponded with nap induction. Finally, β-
galactosidase asssays were performed in high and low nitrate conditons, the 
latter of which is proposed to induce napF expression. 
 
4.3 Methods 
4.3.1  β -Galactosidase Asssays  
S. Typhimurium strains containing a nap-lacZ fusion in WT or a hilA deletion 
background had been previously created. Both strains which contained the 
pMP220 empty vector were used as negative controls.  
 
Aerobic and anaerobic β-galactosidase assays were carried out in order to 
ascertain whether HilA is a co-regulator of SPI-1 and Nap nitrate reductase. 
β-galactosidase is an enzyme encoded by the lacZ gene in the lac operon of 
E. coli. It is a 120kDa protein capable of forming a tetramer that cleaves 
galactose to produce glucose (Juers et al, 2012). The synthetic compound o-
nitrophenyl- β-D-galactosidase (ONPG) is a lactose analogue and is also 
cleaved by β-galactosidase to yield galactose and o-nitrophenol (ONP). ONP 
is a yellow compound and results in a yellow colour change (Juers et al, 
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2012). β-galactosidase assays function on the principle that when ONPG is in 
excess to the enzyme the production of o-nitrophenol is proportional to the 
concentration of β-galactosidase. As a result, measurement of the OD of the 
yellow solution produced allows enzyme concentration to be determined. 
Strains of Salmonella which contained lacZ fused to the napF promoter were 
used in these assays. The acitivity of the napF promoter was determined by 
measurement of β-galactosidase activity, as napF activity should be directly 
proportional to that of β-galactosidase in these strains.  β-galactosidase 
assays were first performed aerobically in plain LB media and then in a high 
salt LB media (LBS) that induced HilA to promote SPI-1 expression. LBS is 
therefore known as SPI-1 inducing conditons. β-galactosidase assays were 
then carried out under anaerobic conditons in M9 minimal media with high 
nitrate and low glycerol (N+/G-) and also conversely, with low nitrate and high 
glycerol (N-/G+). Anaerobic, low-nitrate conditons are thought to be those 
under which napF expression is induced (Rowley et al, 2012). The Miller 
equation (Figure 33) was then used to analyse results and determine napF 
activity.   
 
[(A420 – 1.75 x A550) x 1000] 
(A600 x time x volume of permeabilized cells used) 
 
 
Figure: 33 The Miller Equation. Used to calculate protein of interest 
concentration from activity of β-galactosidase. 
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Figure 34: β- galactosidase cleaves ONPG resulting in a visible colour 
change. ONPG, a colourless, lactose analogue, is cleaved by β- 
galactosidase enzyme, resulting in ONP, a yellow substrate. This results in a 
solution colour change from colourless to yellow.  
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4.4 Results 
4.4.1 HilA is not a transcriptional activator of nap genes in LBS or LB 
media. 
Figure 35 and 36 show results of aerobic β-galactosidase assays performed 
in LB and LBS media respectively. Assays performed aerobically in plain LB 
media (Figure 35) show a 1.25 fold increase in napF activity in the hilA 
deletion background compared to when HilA is present. By comparison 
assays performed aerobically in LBS, SPI-1 inducing conditons, showed no 
difference in napF expression between WT and hilA deletion backgrounds 
(Figure 36). This suggests that HilA is not a transcriptional activator of napF 
under these conditions. 
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Figure 35: Aerobic Luria Broth β-Galactosidase assay pMP220 with napF promoter 
and empty plasmids. Culture diluted in 2ml Z-buffer was lysed with chloroform and 
SDS-page prior to the addition of ONPG. The time taken for a yellow colour to develop 
was recorded and Miller units calculated. 
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Figure 36: Aerobic high salt Luria Broth β-Galactosidase assay pMP220 with napF 
promoter and empty plasmids. Culture diluted in 2ml Z-buffer was lysed with chloroform 
and SDS-page prior to the addition of ONPG. The time taken for a yellow colour to develop 
was recorded and Miller units calculated. 
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4.4.2 HilA is not a transcriptional activator of nap genes in M9 minmal 
media. 
Figure 37 and 38 show results of anaerobic β-galactosidase assays 
performed in M9 minimal media, N-/G+ and N+/G- respectively. Anaerobic 
assays performed in M9 minimal media N-/G+, show a 1 fold increase in napF 
activity in the hilA deletion background (Figure 37). As did anaerobic assays 
performed in M9 minimal media N+/G- (Figure 37).  
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Figure 37: Anaerobic M9 Minimal media with 20mM glycerol, 5mM nitrate, β-
Galactosidase assay pMP220 with napF promoter and empty plasmids. Culture diluted 
in 2ml Z-buffer was lysed with chloroform and SDS-page prior to the addition of ONPG. The 
time taken for a yellow colour to develop was recorded and Miller units calculated. 
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Figure 38: Anaerobic M9 Minimal media 5mM glycerol, 20mM nitrate, β-
Galactosidase assay pMP220 with napF promoter and empty plasmids. Culture 
diluted in 2ml Z-buffer was lysed with chloroform and SDS-page prior to the addition of 
ONPG. The time taken for a yellow colour to develop was recorded and Miller units 
calculated. 
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4.5 Discussion 
SPI-1, which provides the mechanism by which S. Typhimurium invades host 
epithelial cells, is induced by the transcriptional activator HilA. Unpublished 
data by Alston et al (Figure 32) found that SPI-1 genes are co-expressed with 
genes of the nap operon and furthermore that a nap operon deletion mutant 
displayed a 20-30% reduced ability to invade epithelial cells than the WT. As 
such it was proposed that nap may have a role to play alongside SPI-1 in the 
early stages of invasion and that HilA may be a transcriptional activator of nap 
as well as SPI-1. The aim of this chapter was to determine whether or not nap 
was induced by HilA under conditions similar to that of the host intestinal 
lumen where inasion takes place.  
Under SPI-1 inducing conditions, there was no signfiicant difference in napF 
expression regardless of whether HilA was present or absent. In fact, a slight 
increase in napF expression in the hilA deletion background was observed.  
Should HilA, which activates SPI-1 under similar conditons, be an activator of 
napF also, it was expected that napF expression would have been markedly 
increased in the HilA competent background and near negligable when HilA 
was absent. Therefore the results of this study suggest that HilA is not a 
transcriptional activator of napF expression. Results from assays performed 
anaerobically in M9 minimal media displayed corresponding results, including 
the slightly higher activity of the napF promoter in the hilA deletion 
background. Therefore it is possible that HilA may infact exert negative 
regulation on NapF, as activity of the nitrate reductase appears to be slightly 
higher in hilA deletion backgrounds. This aligns with earlier results from Prior, 
2011, who also observed that NapF appeared to undergo negative regulation 
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by HilA under both aerobic and anaerobic conditions. Combined with the prior 
analysis from Alston et al showing a putative hilA box in the napF operon and 
co-expression with SPI-1 genes, this data seems to suggest the possible 
negative regulation of napF by HilA.  
To determine whether HilA does indeed negatively regulate napF, S. 
Typhimurium strains containing a mutation to the hilA promoter region could 
be constructed and napF activity of these strains determined. ChIP-on-chip 
and Electrophoretic Mobility Shift Assays (EMSA) could be employed to 
investigate the interaction of HilA and the napF operon in vivo. Should such 
future work confirm that NapF expression is regulated by HilA then further 
lines of inquiry should examine why such regulation exists and how it benefits 
S. Typhimurium.  
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CHAPTER 5: General Discussion 
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As each chapter has already been individually discussed, I here summarize 
the major outcomes of this study and contextualize these results in the greater 
body of Salmonella research. Additionally I will conclude with suggestions and 
framework for future investigations.  
 
5.1 Context  
5.1.1 Salmonella and Global Health 
Members of the Salmonella genus are bacterial pathogens capable of causing 
mild to fatal disease in humans and mammals. These diseases are 
gastroenteritis, more commonly known as food poisoning, and the more 
severe Typhoid Fever. Current vaccines available for Typhoid offer 
inadequate solution for countries in which the illness is endemic. Furthermore, 
recent years have shown a dramatic and concerning increase in strains of 
antibiotic resistant Salmonella. As such there is a prerequisite for research 
which facillitates the development of novel and effective treatments for 
combating the Salmonella pathogen.  
 
5.1.2 Salmonella and Nitric Oxide 
NO is an essential component of the host innate immune system response to 
pathogens such as Salmonella. It is produced by the iNOS enzymatic 
complex within macrophages following recognition of the PAMPs of invading 
micro-organisms (Umezawa et al, 1997). Mice which lack functional alleles of 
iNOS are considerably more susceptible to Salmonella infection compared to 
mice posessing operative iNOS alleles. Whilst control mice survive 
Salmonalla infection, iNOS-deficient mice subsequently perish from lethal 
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overgrowth of S. Typhimurium in the organs (Mastroeni et al, 2000). Other 
studies have correspondingly shown that prevention of NO synthesis in 
murine models results in significant increase of S. Typhimurium proliferation 
during infection (Umezawa et al, 1997; MacFarlane et al, 1999). MacFarlane 
et al, 1999 demonstrated that when NO is blocked in vivo, mice suffered 
increased mortaility due to an inability to clear Salmonella from the liver and 
spleen and displayed persistant bacteremia compared to untreated control 
mice. Such results substantiate the importance of NO in the control of 
Salmonella infection. 
 
As well as NO, oxidative stress from reactive oxygen species (ROS) function 
as a defence to Salmonella infection. ROS such as the superoxide anion (O2.-) 
and hydrogen peroxide (H2O2) are produced in macrophages in a respiratory 
burst performed by the nicotinamine adenine dinucleotide phosphate reduced 
(NADPH) oxidase as a result of the transient consumption of oxygen (Torres 
et al, 2006). Immune cells such as macrophages which posses the NADPH 
oxidase enzyme can utilize oxidative stress against invading pathogens. 
Highly reactive oxygen species, like RNS, are capable of  damaging the DNA, 
RNA, proteins and lipids of Salmonella (Cabiscol et al, 1999). When O2.- 
reacts with NO the molecule produced is peroxynitrite (ONOO-), an extremely 
powerful oxidant extensively damaging to DNA and other bacterial 
components. The bacteriostatic and bacteriocidal effects of such ROS and 
RNS make them a considerable impediment to Salmonella survival. As such, 
it is unsurprisng that Salmonella has developed mechanisms by which to 
withstand both of these stressors.  
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5.1.2.1 Nitric Oxide detoxfication 
The role of the metalloenzyme flavohaemoglobin (HmpA), encoded by hmpA 
in Salmonella, is well characterised in NO detoxification. NO is oxidized to 
nitrate by HmpA in aerobic conditions or reduced to nitrous oxide by HmpA in 
anaerobic conditions. The enzyme is activated in the presence of NO, with its 
expression demonstrated to be highly induced in S. Typhimurium inside 
macrophages (Prior et al, 2009). The relevance of HmpA in NO detoxification 
is supported by the attenuation of S. Typhimurium hmpA mutants inside 
macrophages and by studies showing HmpA-deficient mice perish from S. 
Typhimurium infection before they can produce a nitrosative burst. As such, 
flavohaemoglobin has an evident role in Salmonella survival where it appears 
to be the prevailing enzyme in NO detoxification. However, other genes have 
been identified which may share involvement in NO resistance and 
detoxification in Salmonella. The exploration of other such potential NO 
detoxification genes is a focus of this research.  
 
This study is based on preliminary data indicating that a number of largely 
uncharacterized S. Typhimurium genes were upregulated in response to 
nitrosative stress. The aim of this research was therefore the investigation and 
characterisation of these genes and their potential involvement in S. 
Typhimurium nitrosative and oxidative stress resistance.  
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5.2 Characterisation of possible NO-detoxifing genes  
5.2.1 Mutants: Construction and Growth Curves  
Mutant strains of the genes of interest were constructed using phage λ red 
recombination as has been previously described. Resulting bacterial colonies 
were checked for the presence of the internal pKD3 or pKD4 antibiotic 
resistance casette by PCR amplification with both external and internal 
verification primers, therefore confirming successful mutagenic strains. This 
process yielded twelve distinct mutants, including single, double, triple and 
quadruple mutant strains. 
 
Before sensitivity to either oxidative or nitrosative stressors could be 
examined it was vital to determine whether any of the mutant strains 
displayed growth defects as a result of their mutation, as any such 
deficiencies would unfairly distort later data. All mutant strains were therefore 
grown alongside the isogenic parental strain SL1344 (WT) in nutrient rich LB 
media for a period of 24 hours with growth measured hourly up to the 8th hour 
by the OD600 of a 1mL aliquot. Encouragingly, all strains showed growth rates 
akin to that of the WT strain and reached similar final optical densities.   
 
5.2.2 Mutants: Sensitivity towards NO  
Once it had been established that all mutant strains displayed normal growth 
patterns and rates, the strains were exposed to nitrosative stress in the form 
of detaNONOate in order to examine whether they showed increased 
sensitivty to NO in comparison to the S. Typhimurium WT. Strains were 
subjected to the NO donor Deta NONOate at physiologically relevant levels 
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under both anaerobic and aerobic conditons. Deta NONOate spontaneously 
dissociates in a pH-dependent manner to release 2 moles of NO per mole of 
parent compound and has been used previously by the Rowley lab. The 
examination of mutant sensitivty to NO under both aerobic and anaerobic 
conditons allowed determination of whether mutated genes showed varied 
involvement in NO detoxification depending on oxygen availability, as in the 
case of the metalloenzymes hmpA, norV and nrfA. 
 
Under aerobic conditions single mutants ∆STM1250, ∆STM4452, ∆STM1586,  
∆STM3362 and ∆ycfR do not appear to be more sensitive to NO than WT 
SL1344. However the considerably hindered growth of the ∆STM1808-yeaR-
tehB-HmpA quadruple mutant, priorly shown to be highly susceptible to NO 
killing, demonstrated that the assay was functioning. When the assay was 
performed again under anaerobic conditons, mutants similarly did not display 
increased sensitivity to NO compared to the WT strain. In fact, mutant strains 
seemed to show improved survival over the SL1344 WT strain. Such results 
suggest that these single genes are not involved in NO detoxification as their 
absence does not hinder bacterial growth in the presence of NO. This 
includes ∆ycfR which has previously shown to be a resistance gene in both E. 
coli and Salmonella against oxidative and other stresses and was therefore 
most expected to show increased NO senstivity (Eletsky et al, 2014).  
 
Aerobic and anaerobic NO sensitivity assays were also carried out with 
∆STM1250, the double mutants ∆ibpA-ibpB and ∆STM1250-STM1251, and 
the quadruple mutant ∆ibpA-ibpB-STM1250-STM1251. ∆STM1808-yeaR-
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tehB-HmpA was again used to demonstrate the functionality of the assay. In 
both aerobic and anaerobic conditions all multiple mutants displayed 
increased sensitivity to NO in comparison to the WT strain. Under anaerobic 
conditons both ∆ibpA-ibpB and ∆STM1250-STM1251 show similar sensitivity 
to NO, surprisingly greater than that of the quadruple mutant. However under 
anaerobic conditons, ∆ibpA-ibpB  displayed the greatest sensitivity out of all 
mutants, followed by ∆ibpA-ibpB-STM1250-STM1251 and with ∆STM1250-
STM1251 the least effected. Such results suggest that STM1250, STM1251 
and their homologues ibpA and ibpB may have a role in Salmonella survival of 
nitrosative stress, but that STM1250 and STM1251 may be less vital and 
active more so under aerobic conditions. This is supported by the absence of 
STM1250 and STM1251 in similar microorganisms such as E. coli, which are 
able to withstand NO killing without either of these genes. As previously 
suggested, it is possible that the double mutant ∆ibpA-ibpB is more sensitive 
to NO than ∆ibpA-ibpB-STM1250-STM1251 due to some compensatory 
mechanism acting in the latter, which is active due to both ibpA, ibpB and its 
homologues, STM1250 and STM1251, being knocked-out. It is possible the 
bacterium recognizes the absence of both homologue pairs and the resulting 
compensation improves bacterial resistance to NO above that of the ∆ibpA-
ibpB mutant. IbpA and IbpB are both heat shock proteins upregulated under 
stressors such as heat, oxidative stress and acid where they act as 
chaperones for damaged proteins. IbpA and IbpB interact in an as yet 
undefined manner and localise to the denatured protein, utimately facilitating 
its refolding. It has been demonstrated that an absence of IbpA and IbpB 
results in increased aggregation of proteins in E. coli cells under heat stress 
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(Matuszewska et al, 2008).  Whilst there is no evidence in the current 
literature of their action in relation to nitrosative stress, the role of IbpA and 
IbpB in general stress response, their up-regulation in micrroaray data 
together with results of this study make it a distinct posibility that they aid in 
Salmonella resistance to NO killing.  
 
As results from both sensitivity and susceptibility assays showed ∆ibpA-ibpB-
STM1250-STM1251 to be more greatly effected by NO than the WT strain the 
next step was to determine the contribution of the homologous pairs 
composing this quadruple mutant to NO resistance. To further investigate the 
individual NO sensitivity of ∆ibpA-ibpB, ∆STM1250-STM1251 and ∆ibpA-ibpB-
STM1250-STM1251 a technique known as an oxidative stress susceptibility 
assay described in Testerman et al, 2002 was adapted for nitrosative stress. 
Deta NONOate was again employed as an NO donor and was added to strain 
cultures in the respective quantites of 0mM and 7.5mM. Results from this 
assay further complement those achieved by NO sensitivity assays, with 
∆ibpA-ibpB the most susceptible to NO killing and ∆STM1250-STM1251 the 
least effected by NO. This supports the before mentioned theory that while 
STM1250 and STM1251 are involved in NO stress resistance, IbpA and IbpB 
play the more significant role of the two homologous pairs in NO 
detoxification.  
 
5.2.3 Mutants: Sensitivity to H2O2 
As ROS are also an important part of the host innate immune response to 
Salmonella infection, the multiple mutants which showed sensitivity to NO 
	 151	
were then exposed to hydrogen peroxide as a source of oxidative stress. Two 
distinct assays were utilized to determine whether multiple mutants were more 
sensitive to oxidative stress than the WT; sensitivity assays, as as had been 
previously performed for nitrosative stress, and oxidative stress susceptibility 
assays as per Testerman et al. 
 
Sensitivity assays were performed with ∆STM1250, ∆ibpA-ibpB, ∆STM1250-
STM1251 and ∆ibpA-ibpB-STM1250-STM1251 to determine sensitivity to 
oxidative stress, provided in the form of 3mM hydrogen peroxide. Results 
suggest that mutant strains are more sensitive to oxidative stress than the WT 
strain, with ∆ibpA-ibpB showing the greatest sensitivity. This reflects results 
achieved for nitrosative stress sensitivity assays, where growth of ∆ibpA-ibpB 
was most affected. Similarly, this result is not unpresedented as IbpA and 
IbpB have both previously been shown to have a role in resistance to 
oxidative stress in E. coli. Kitagawa et al, constructed IbpA, IbpB and IbpAB-
overexpressing strains which were found to be more resistant to both 
oxidative stress and heat stress than the E. coli WT strain. E. coli strains 
deficient in ibpA and ibpB also appear to be more sensitive to superoxide 
radicals generated by tellurite (Perez et al, 2007). Similarly Matsuszewka et 
al, demonstrated that IbpA and IbpB were involved in resistance to copper 
induced oxidative stress in E. coli cells. Most recently it was observed that 
IbpA and IbpB are upregulated in non-pathogenic E. coli in an ROS-
dependent manner in macrophages, which then serves to protect the 
bacterium from oxidative stress (Goeser et al, 2015). Such evidence supports 
the findings of this study. It is therefore likely that both ibpA and ibpB are 
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somehow involved in both nitrosative and oxidative stress tolerance in S. 
Typhimurium. 
 
Oxidative stress susceptibility assays, performed with the ∆ibpA-ibpB-
STM1250-STM1251 and ∆STM3362-ycfR-ybiJ triple mutant in comparison to 
the WT strain, showed ∆ibpA-ibpB-STM1250-STM1251 to be the most 
susceptible to oxidative stress. ∆STM3362-ycfR-ybiJ also showed increased 
sensitivity to H2O2 in comparison with the WT, though to a lesser degree than 
∆ibpA-ibpB-STM1250-STM1251. As such it is plausible that the individual 
genes STM3362, ycfR and ybiJ may be involved in oxidative stress resistance 
in Salmonella. All share a domain of unknown function, DUF1471, which has 
been found to be present largely in proteins involved in the stress responses 
of Salmonella and E. coli (Eletsky et al, 2014). Little is known about this 
domain or the majority of proteins containing it apart from this, but results here 
suggest that genes such as STM3362, ycfR and ybiJ may indeed have minor 
roles in oxidative stress tolerence. 
 
5.3 Mutants: Conclusions 
Therefore, whilst a number of genes were shown to be up-regulated in the 
initial microarray, results of both sensitivity and susceptibility assays failed to 
show increased NO sensitivity in ∆STM1250, ∆STM4552, ∆STM1586, 
∆STM3362 or ∆ycfR.  However, the triple mutant ∆STM3362-ycfR-ybiJ 
demonstrated susceptibility to oxidative stress and multiple mutants 
∆STM1250-STM1251, ∆ibpA-ibpB and ∆ibpA-ibpB-STM1250-STM1251 all 
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demonstrated increased susceptibility to both NO and H2O2, suggesting a role 
for these genes in Salmonella oxidative and nitrosative stress resistance.  
 
5.4 HilA and the regulation of Nap nitrate reductase  
5.4.1 Context 
As a faculative anaerobe Salmonella is capable of switching to nitrate 
respiration, allowing it to survive in oxygen-limited conditions. This is known 
as the dissimilatory from nitrate to ammonium, or DNRA pathway, where 
Salmonella produces energy for respiration by reduction of nitrate to nitrite via 
nitrate reductase enzymes. NO is a by-product of this reduction of nitrate, 
which itself undergoes truncated dentrification to nitrous oxide (N2O) 
(Sparacino-Watkins et al, 2014). 
 
Salmonella synthesises two distinct enzymes which reduce nitrate to nitrite; a 
cytoplasmic membrane bound enzyme known as NarG, and the periplasmic 
nitrate reductase, NapA.  In the cytoplasm, NarGHI reduces nitrate to nitrite, 
and NirB further reduces this nitrite to ammonium, whilst in the periplasm, 
NapA reduces nitrate to nitrite and a periplasmic cytochrome c nitrite 
reductase (NrfA) performs the conversion to ammonium. It is thought that 
under nitrate-limited conditions Nap is unregulated and performs as the main 
nitrate reductase, as it has a higher affinity for nitrate, whilst under nitrate-rich 
conditions, Nar is utilised (Rowley et al, 2012). 
 
Whilst little is known about the regulation of Nap, preliminary data revealed 
that the expression of five genes of the napF operon overlapped with those of 
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SPI-1 in hierarchal cluster analysis. SPI-1 encodes the type three secretion 
system (TTSS) of Salmonella and most associated effector proteins 
responsible for the bacterium’s invasion capabilities. SPI-1 itself is controlled 
by the master regulator and transcriptional activator, Hyperinvasion Locus 
Protein A, otherwise known as HilA. It was therefore proposed that HilA might 
possibly also regulate the napF operon, and furthermore, that clustering of 
SPI-1 and Nap genes might indicate a potential role for Nap in Salmonella 
invasion. This study therefore aimed to investigate whether HilA is a regulator 
of nitrate reductase, NapA. 
 
5.4.2 HilA as a possible negative regulator of Nap  
To determine whether HilA is a regulator of the napF operon, S. Typhimurium 
strains containing a nap-lacZ fusion were utilized in both aerobic and 
anaerobic β-galactosidase assays. Different in vivo conditions were simulated 
by use of varied media, including rich LB media and high-salt LBS, the latter 
of which is known to induce the expression of SPI-1 and therefore HilA. 
Should HilA act as a positive regulator of NapA, the enzyme’s expression 
should be highest under SPI-1 inducing conditions.  
 
Whilst experiments in LB and LBS were performed aerobically, cultures grown 
in M9 minimal media were done so anaerobically. Both low nitrate, high 
glycerol M9 (N-/G+) and high nitrate, low glycerol M9 (N+/G-) media was used, 
with the former being theoretically the ideal conditions for the induction of 
NapA expression.  
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However, assay results from all media conditions suggest that HilA is not a 
positive regulator of the napF operon, as the fusion strain possessing hilA did 
not show increased NapA expression in comparison to the hilA deletion strain 
under any media conditions. Conversely, in all conditions, particularly that of 
aerobic LB cultures, NapF expression is slightly higher in the hilA deletion 
mutant. This unexpected result seems to suggest an inhibitory role for HilA in 
regards to NapF. Although no current literature addresses the possibility of 
HilA as a transcriptional repressor, results achieved here reflect those 
achieved previously by Prior, 2011, in which slightly higher activity of NapF in 
the hilA deletion background was again observed. It is therefore the 
conclusion of this study that HilA may exert a negative regulatory effect on the 
Nap nitrate reductase of Salmonella.  
 
5.4 Future work and concluding remarks  
STM3362, ycfR and ybiJ were not individually examined for sensitivity to 
oxidative stress, so their individual contribution to the oxidative stress 
tolerance of S. Typhimurium is unknown. In light of results demonstrating 
∆STM3362-ycfR-ybiJ susceptibility to oxidative stress, H2O2 sensitivity assays 
should be performed comparing ∆STM3362, ∆ycfR, ∆ybiJ ∆STM3362-ycfR-
ybiJ oxidative stress sensitivity to that of the WT. Similarly, nitrosative stress 
sensitivity assays should be performed in the same manner, as neither ∆ybiJ 
nor ∆STM3362-ycfR-ybiJ were examined for sensitivity to NO within this 
study. This would allow determination of whether ∆STM3362-ycfR-ybiJ 
displays susceptibility to nitrosative stress as well as oxidative stress.  
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Results of this study demonstrate that ∆ibpA-ibpB is considerably more 
sensitive to NO than ∆STM1250-STM1251 under aerobic conditons, however 
both mutants display similar NO sensitivity in anaerobic conditons. This may 
indicate that STM1250 and STM1251 contribute more to NO resistance under 
anoxic conditons than they do in aerobic environments or that ibpA and ibpB 
are more protective against NO killing under aerobic conditions than 
anaerobic ones. Based on strain survival across the two assays the latter 
appears to be the more plausible possibility, however further NO sensitivity 
assays would be required to determine this. 
 
Following further examination of the sensitivity of mutant strains, future 
research should focus on cell culture. Gentamicin sensitivity assays in both 
resting and IFN-γ activated macrophages should be performed to assess the 
ability of mutant strains to infect and survive in macrophages in comparison 
with the WT strain. Of particular interest will be the double mutant ΔibpA-ibpB 
and the quadruple mutant, ΔibpA-ibpB-STM1250-STM1251, which both 
displayed oxidative and nitrosative sensitivity.  
 
A further worthwhile venture would be the transformation of GFP-plasmids 
into mutant strains, allowing for observation of intracellular trafficking and 
survival of both mutants and WT inside macrophages, both in the absence 
and presence of NO-inhibitors. If mutants display particular sensitivity to NO-
killing the introduction of an NO-inhibitor such as L-NAME or L-NIL would be 
expected to rescue mutant strain expression. The interaction of mutant strains 
and NO could also potentially be observed by use of a flourescence based 
	 157	
NO-sensor to investigate the interaction of NO and mutants within 
macrophages.  
 
As results of this study suggest that HilA may negatively regulate Nap future 
work should seek to confirm this by use of hilA mutants, as well as ChIP-on-
chip and ESMA.  
 
To conclude, this study suggests roles for various genes, such as ibpA and 
ibpB in NO detoxification and survival of oxidative stress in S. Typhimurium. 
However further investigation in live cell cultures is needed to fully elucidate 
the role of such genes and their importance in resistance to nitrosative stress.  		
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